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 ABSTRACT 
 
The voltage-gated potassium channel Kv1.2 impacts membrane potential 
and therefore excitability of neurons. Expression of Kv1.2 at the plasma 
membrane (PM) is critical for channel function, and altering Kv1.2 at the PM is 
one way to affect membrane excitability. Such is the case in the cerebellum, a 
portion of the brain with dense Kv1.2 expression, where modulation of Kv1.2 at 
the PM can impact electrical activity of neurons and ultimately cerebellum-
dependent learning. Modulation of Kv1.2 at the PM can occur through endocytic 
trafficking of the channel; however mechanisms behind this process in the brain 
remain to be defined. 
The goal of this dissertation was to identify and characterize modalities 
endogenous to the brain that influence the presence of Kv1.2 at the neuronal 
plasma membrane. Mass spectrometry (MS) was used to first identify interacting 
proteins and post-translational modifications (PTM) of Kv1.2 from cerebellar 
tissue, and the roles of these interactions and modifications on Kv1.2 function 
were evaluated in two studies: 
The first study investigated Trim32, a protein enzyme that catalyzes 
ubiquitylation, a PTM involved in protein degradation, but also in non-
degradative events such as endocytic trafficking. Trim32 was demonstrated to 
associate and localize with Kv1.2 in cerebellar neurons by MS, immunoblotting 
(IB), and immunofluorescence (IF), and also demonstrated the ability to 
ubiquitylate Kv1.2 in vitro through purified recombinant proteins. Utilizing 
cultured cells through a combination of mutagenesis, biochemistry, and 
quantitative MS, a working model of Kv1.2 modulation was developed in which 
Trim32 influences Kv1.2 surface expression by two mechanisms that both involve 
cross-talk of ubiquitylation and phosphorylation sites of Kv1.2.  
The second study investigated WNK1, a chloride-sensitive kinase which 
regulates cellular homeostasis. Using MS, IB, and IF, WNK1 was demonstrated 
to associate and localize with Kv1.2 in the cerebellum, and a combination of 
mutagenesis and pharmacology in both wild-type and WNK1-knockout cultured 
cells produced a working model whereby WNK1 modulates surface Kv1.2. 
Activation of the downstream target SPAK kinase, also identified by MS to 
associate with Kv1.2 in the brain, by WNK1 was additionally found to influence 
the manner of WNK1 modulation of Kv1.2. 
In addition to providing new models of Kv1.2 modulation in the brain, 
these studies propose novel biological roles for Trim32 and WNK1 that may 
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
 
Proteins are essential to life, and how proteins contribute to cell function is a 
fundamental question in science (Eisenberg, Marcotte, Xenarios, & Yeates, 2000). 
Around the turn of the 21’st century, large-scale genomic sequencing facilitated the 
development of computational methods to identify shared functional properties among 
proteins, often by inference from sequence and structural homology (Eisenberg et al., 
2000). However, these methods can be limited by the fact that an individual protein’s 
function is often critically dependent on the larger protein complex in which it is found as 
well as on its post-translational modification state (Gingras, Gstaiger, Raught, & 
Aebersold, 2007; Spirin & Mirny, 2003; Stoilova-McPhie, Ali, & Laezza, 2013). Mass 
spectrometry (MS) is a tool that can provide information about both of these key 
parameters. Indeed, MS is now perhaps the best method for identifying the specific 
components of a protein complex, as well as the specific sites and types of post-
translational modification, that actually exist in living organisms (Aebersold & Mann, 
2003). As with any tool, protein peptide identification by MS is not without 
shortcomings, drawbacks, and pitfalls, particularly at the level of analysis, (Lubec and 
Afjehi-Sadat, 2010) and careful considerations must be made during sample preparation 
and analysis. Given this strength of MS, this approach was used as a starting point and 
foundation for the data presented in Chapters 2 and 3. Both chapters present evidence for 
unique regulation and trafficking of voltage-gated ion channels; Chapter 2 presents data 
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for regulation by ubiquitylation and the ubiquitin ligase Trim32 while Chapter 3 presents 
data for regulation by atypical WNK1 and SPAK kinases. The following literature review 
is intended to provide additional background for the major topics discussed in the 
chapters that follow. 
Protein Post-Translational Modification 
Overview of Protein Post-Translational Modification 
 Protein function is often regulated by some type of post-translational 
modification. Extracellular and intrinsic signals are modulated and fine-tuned by PTMs, 
which regulate protein functioning, trafficking, and survival. PTMs also can assist with 
general biological processes such as cell signaling, proliferation, migration, and 
interaction with other cells (Doerig, Rayner, Scherf, & Tobin, 2015). PTMs can occur at 
any point in the life cycle of the protein.   
Shortly after translation, PTMs can assist with the proper folding, stability, and 
biosynthetic trafficking of proteins (Dunham et al., 2012). Once properly folded and 
localized, PTMs can continuously influence the catalytic and overall biological activity of 
the protein. Once a protein reaches the end of its life cycle, PMTs serve as tags to mark 
its eventual destruction. Ultimately, PTMs impact a protein throughout the entirety of its 
lifespan. 
The human proteome consists of enzymes such as kinases, phosphatases, 
transferases, ligases, and others which perform over 200 types of PTMs by adding, 
removing, or transferring modification groups.  Examples of PTM modification groups 
include: addition of methyl and acetyl groups to a lysine for histone code development on 
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chromatin, palmityl groups to a cysteine to help drive protein association with 
membranes, N-acetylglucosamine to a serine/threonine to control enzyme activity and 
gene expression in glucose homeostasis, among many others (Pawson & Nash, 2003). 
The following sections will focus on two of the most common PTMs, phosphorylation 
and ubiquitylation, which influence the dynamic trafficking of mature proteins at the 
plasma membrane.  
Protein Phosphorylation 
Phosphorylation is the most prevalent and understood post-translational 
modification. Approximately one-third of proteins in the human proteome are estimated 
to be a substrate for phosphorylation at some point in the protein lifespan (P. Cohen, 
2000). Protein phosphorylation is the process of attaching the chemical phosphate group 
(PO43-) to a protein. In Eukaryotic cells, phosphorylation occurs primarily on a serine, 
threonine, or tyrosine but in some rare cases also histidine and aspartate (Thomason & 
Kay, 2000). Attachment of the phosphate group alters the proteins electrostatic properties 
and often induces a conformational change that alters activity and/or recruit of 
downstream proteins. The effects of phosphorylation on protein function are varied, and 
multiple modifications within a single protein can lead to complex outcomes (Barford, 
Das, & Egloff, 1998; Pawson & Nash, 2003; Pellicena & Kuriyan, 2006). 
Protein Kinases 
A protein kinase is responsible for transferring the phosphate group to a protein 
substrate. Protein kinases are involvement in coordination of nearly every cellular 
process, as the activity, localization, and overall function of many proteins is directed by 
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kinase phosphorylation. Protein kinases deliver a single phosphoryl group from ATP to 
the ɤ position to the hydroxyl group (-OH) oxygen on a serine, threonine, or tyrosine side 
chain of a protein. This process can be rapidly reversed by protein phosphatases which 
remove the phosphate group and release it back into solution. Together, protein kinases 
and phosphatases provide a back and forth mechanism that dynamically regulates the 
homeostasis of a protein’s phosphorylation state (collectively reviewed in (Cheng, Qi, 
Paudel, & Zhu, 2011)).  
Approximately 2% of human genes encode for protein kinases. Of the 518 protein 
kinases, 478 belong to a single superfamily with related catalytic domain sequence 
(Manning, Whyte, Martinez, Hunter, & Sudarsanam, 2002). Various kinase classification 
methods have been developed, most of which separate them into groups and families 
based on similarity of sequence and biochemical functionality (Martin, Anamika, & 
Srinivasan, 2010).  
Protein kinases are highly conserved throughout evolution. Prior to the discovery 
of atypical kinases, one of the many conserved subdomains encompassing the catalytic 
core, subdomain II, contains a lysine residue that was, at the time, present in all protein 
kinase catalytic domains. Mutation of this lysine can render a kinase catalytically 
inactive, which is also proximally close to the ATP molecule and suggested to be 
involved in the stabilization and binding of ATP and the phosphate transfer process. This 
invariant lysine was described as crucial for binding ATP (Carrera, Alexandrov, & 
Roberts, 1993). At the turn of the century, however, a new group of kinases were 
discovered that appeared to catalyze phosphorylation without this crucial lysine. 
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Atypical WNK Protein Kinases 
WNK (With-No-Lysine) kinases are a four member group (WNK1-4) of atypical 
serine/threonine protein kinases. Their atypical subcategorization results from the unusual 
placement of the conserved, catalytic lysine of subdomain II that is replaced by a cysteine 
residue (Figure 1). The group that first characterized these kinases originally believed the 
catalytic lysine was simply missing and called them “With-No-Lysine” (B. Xu et al., 
2000). However, within the same initial study, the group also determined lysine 233 
(K233) in human WNK1, which is found within kinase subdomain I and conserved 
across all WNK homologs, is critical for catalytic activity, and mutation of this lysine to 
methionine disrupted kinase activity (B. Xu et al., 2000). The crystal structure of WNK1 
later showed that the folding structure of active WNK1 actually positions K233 to a 
location analogous to the lysine normally conserved within subdomain II, and that 
inactive WNK1 actually adopts a conformation that pulls the lysine out of catalytic 
position (Min, Lee, Cobb, & Goldsmith, 2004). WNK1 remains the best characterized of 
the four isoforms. The functional role of WNK kinases within human renal function has 





Figure 1:1 Structure of WNK1.  Top: Highlights the kinase domain and length of 
WNK1. Bottom: Ribbon representation of the crystal structure of the WNK1 highlighting 
the unusual placement of the catalytic lysine, K233, which is found within β strand 2 
rather than strand 3 of other kinases. The red circle highlights K233 and the typical lysine 
location where, instead, a cysteine is found (C250). 
Image adapted with permission from work published by Min et al. Crystal Structure of the Kinase 
Domain of WNK1, a Kinase that Causes a Hereditary Form of Hypertension. Structure. 2004 July; 
12(7) 1303-1311. 
 
WNK Signaling in the Kidney 
 WNK kinases maintain cellular homeostasis by sensing changes in intracellular 
chloride, cell volume, and extracellular osmolarity, and respond by adjusting the transport 
of sodium (Na+), potassium (K+), and chloride (Cl-) through regulation of reciprocal 
cation-chloride co-transporters (CCC) (reviewed collectively in (Alessi et al., 2014)). In 
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the distal convoluted tubule of the kidney, WNK kinases are highly expressed where they 
sit atop of a signaling pathway in the regulation of CCCs.   
WNK kinases influence cation-co-transporters through activation of immediately 
downstream SPAK/OSR1 kinases (Figure 2). SPAK and OSR1 associate with both 
WNKs and CCCs by docking their conserved carboxyl-terminal domain (CCT) with 
RFXV/I motifs on WNKs and CCCs. Association of WNKs with SPAK/OSR1 allows 
WNKs to phosphorylate and activate SPAK/OSR1, while association of SPAK/OSR1 
with CCCs allows SPAK/ORS1 to phosphorylate and traffic CCCs. Members of the 
WNK family bind SPAK/ORS1 differently, however, and can have different impacts on 
cellular signaling. For example, WNK1 phosphorylates and activates SPAK/OSR1 up to 
10 fold more than WNK4 (Bazua-Valenti & Gamba, 2015), and its SPAK induced 
activation of NCC can be antagonized by WNK4 (Chavez-Canales et al., 2014). Aside 
from regulating cation transport through SPAK/OSR1 induced CCC trafficking, WNK 





Figure 1:2 Proposed mechanism by which the WNK-SPAK/OSR1 signaling 
pathway regulates salt re-absorption and blood pressure.  Osmotic stress can trigger 
WNK1 to induce trafficking of cation co-transporters through activation of downstream 
SPAK/OSR1. This process occurs by a series of phopshorylations: osmotic stress induces 
autophosphorylation and activation of WNK1, and activated WNK1 phosphorylates 
SPAK/OSR1 which, in turn, phosphorylates and trafficks cation-cotransporters. WNK4 
can oppose this process.  
Image obtained with permission from work originally published by Ciaran Richardson, and Dario R. 
Alessi.  J Cell Sci. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 




Protein Trafficking by WNK kinases Beyond Cation-co-transporters 
WNK-SPAK regulation of CCCs in the kidney is rather well established, however 
the WNK-SPAK kinase network has been shown to influence other protein trafficking. 
WNK kinases activate endocytosis of renal outer medullary potassium (ROMK) 
channels, inward-rectifier potassium (Kir) which transport K+ out of cells (Zagorska et 
al., 2007). SiRNA knockdown of endogenous WNK1 in cultured cells increases ROMK1 
surface expression, and it was demonstrated that a complex of WNK1-WNK4 binds the 
endocytic scaffolding protein intersectin to induce clathrin-dependent endocytosis of 
ROMK1 independent of SPAK/OSR1 (He, Wang, Huang, & Huang, 2007; C. L. Huang, 
Yang, & Lin, 2008; Lin, Yue, Zhang, & Wang, 2014). Additionally, WNK4 inhibits renal 
large-conductance Ca(2+)-activated K(+) (BK) by reducing their surface and whole cell 
expression through enhanced ubiquitination mediated lysosomal degradation (Z. Wang et 
al., 2013; Yue, Zhang, Lin, Sun, & Wang, 2013), while in contrast, WNK1 enhances BK 
channel function by reducing lyosomal degradation (Y. Liu et al., 2015). WNK1 also 
activates the serum and glucocorticoid-regulated kinase 1 (SGK1) to enhance activation 
of the epithelial sodium channel (ENaC) (B. E. Xu, Stippec, Chu, et al., 2005; B. E. Xu, 
Stippec, Lazrak, Huang, & Cobb, 2005). Together, these examples demonstrate that in 
addition to CCCs, WNK kinases can also traffic ion channels. 
WNK Expression and Connection to Hypertension 
 
WNK1 is expressed ubiquitously in mice as early as embryonic days E8-9 with 
enrichment in the cardiovascular system. During development, WNK1 knockout mice 
have cardiac deficits and impaired angiogenesis as early as E10.5 and failed vascular 
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system remodeling leads to death in utero by E13.5 (Delaloy et al., 2006; J. Xie et al., 
2009). Interestingly, the angiogenic and cardiac defects were nearly identical in global 
and endothelial-specific OSR1 knockout mice, and knockin of endothelial-specific 
constitutively active OSR1 rescued the defects (J. Xie, Yoon, Yang, Lin, & Huang, 
2013), demonstrating that the WNK-SPAK/OSR1 signaling pathway is crucial for proper 
development.  
As demonstrated by the transgenic mouse models, altered expression of kinases 
within the WNK signaling pathway can have severe physiological consequences, and 
likewise can impact human health. Mutations in the WNK1 and WNK4 genes cause a 
type of hereditary hypertension known as pseudohypoaldosteronism type II (PHAII) 
(reviewed in (Bazua-Valenti & Gamba, 2015)). Patients with PHAII have disrupted 
regulation of ion transport, resulting in hypertension, hyperkalemia, and hyperchloremic 
metabolic acidosis. Overall, conditions that result in increased expression of WNK 
kinases seem to result in PHAII (Susa et al., 2014).  
Clinical features of PHAII can be explained by impaired ubiquitylation of WNK 
kinases (Shibata, Zhang, Puthumana, Stone, & Lifton, 2013). WNK4 reduces surface 
expression of ROMK, and ubiquitylation of WNK4 signals kinase degradation and results 
in increased ROMK at the surface. A mouse model for PHAII where mice have a single-
copy BAC transgene including the human genomic locus containing the WNK4 Q562E 
allele present hypertension and hyperkalemia similar to humans with the same mutation. 
These mice were found to have significantly higher levels of WNK4 in the distal nephron 
in the kidney compared to mice expressing WNK4WT, and the increased WNK4 was 
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reported to be from impaired degradation. Increased WNK4 will result in a relative 
elimination of ROMK, a trait that contributes to hyperkalemia in PHAII (Lalioti et al., 
2006). Similarly to genetic mutations impairing WNK4 degradation, genetic mutations 
that disrupt the catalytic activity of the ubiquitin ligases that catalyze WNK4 
polyubiquitylation cause PHAII. In fact, within a study of 52 families with PHAII, ~80% 
of the disease was caused by ubiquitin ligase mutation. Therefore, although PHAII is 
attributed to the change in expression and activity of kinases, ubiquitin ligases are the 
primary culprits behind the disease (Herrera & Coffman, 2013). 
Protein Ubiquitylation 
 Following phosphorylation, recent advances in proteomics have identified 
ubiquitylation (or ubiquitination) as one of the next most abundant and versatile PTMs in 
mammalian tissue (W. Kim et al., 2011). In a similar historical context to 
phosphorylation (reviewed in (P. Cohen, 2002)), several decades following the discovery 
of ubiquitin passed before its functional role breached confinement of a single signaling 
mechanism in the scientific literature, however ubiquitylation is now accepted as a major 
signaling event involved with a myriad of biological events (Chen & Sun, 2009; 
Komander, 2009).  
Protein ubiquitylation involves the attachment of the ubiquitin protein to a protein 
substrate. Discovered by Hershko and colleagues in 1978, the small ubiquitin protein was 
originally reported as a required component for the proteasome to breakdown proteins in 
cell extracts (Ciehanover, Hod, & Hershko, 1978). Aaron Ciechanover, Avram Hershko 
and Irwin Rose were later awarded the Nobel Prize in Chemistry in 2004 for this 
12 
 
discovery (Giles, 2004). Work particularly within the lab of Varshavsky and colleagues 
in living mammalian cells throughout the 1980s caused a radical change in the general 
understanding of intracellular circuits, as they identified the ubiquitin system was 
essential for the majority of protein degradation in living cells, required for cell viability, 
and performed major roles in the cell cycle, DNA repair, protein synthesis, transcriptional 
regulation, and other processes (reviewed in (Varshavsky, 2006)). These discoveries 
sparked a massive expansion of the ubiquitin field in the 1990s. Now, ubiquitylation has 
been demonstrated to assist orchestrating a plethora of physiological functions.  
  Ubiquitin-protein ligation requires three enzymes (Hershko, Heller, Elias, & 
Ciechanover, 1983) in a three step, sequential action: First, a ubiquitin-activating enzyme 
(or E1) utilizes ATP to activate the C-terminal glycine reside of ubiquitin (release of PPi 
and AMP). Next, activated ubiquitin is then transferred to an active-site cysteine reside of 
a ubiquitin-conjugating enzyme (or E2). Finally, ubiquitin is transferred to a ubiquitin-
ligating enzyme (or E3) which ligates the C-terminal glycine residue of ubiquitin in an 
amide isopeptide-linkage to the ɛ-amino group of an internal lysine or α-amino group of 
the N-terminal methionine residue in the target protein (Hershko & Ciechanover, 1998).  
The covalent bond between substrate lysine and ubiquitin glycine has been 
fruitful for modern proteomic identification of ubiquitylation, as ubiquitylated proteins 
digested with trypsin (a serine protease which cleaves the carboxy-terminal end of lysine 
and arginine amino acids) will result in peptides still containing -K-ε-GG motif following 
cleavage of bound ubiquitin from -K-ε-GG(cut)-R-ubiquitin. In addition to the diagnostic 
advantages of this 114.0429 Da motif, anti-K-ε-GG antibodies have allowed advanced 
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enrichment of ubiquitylated proteins prior to digest and greatly expanded the detected 
sites among the literature yielding over 10,000 unique sites on over 4,000 proteins (W. 
Kim et al., 2011; Udeshi et al., 2013; Wagner et al., 2012). This approach has led to 
similar growth in depth of global phosphorylation and acetylation studies (Choudhary et 
al., 2009; Huttlin et al., 2010; S. C. Kim et al., 2006; Olsen et al., 2006). 
Ubiquitylation, like phosphorylation, is a reversible process and undergoes 
counter regulation by the activity of isopeptidases known as deubiquitinating enzymes 
(DUBs) (Clague, Coulson, & Urbe, 2012) that function analogously to the removal of 
phosphate by protein phosphatases. An estimated 100 deubiquitinating enzymes within 
mammalian cells reverse ubiquitylation by rapidly removing ubiquitin from substrates at 
various signaling checkpoints and recycle ubiquitin for further modification (Reyes-
Turcu, Ventii, & Wilkinson, 2009). Activity coordination between the E3 ligases and 
deubiquitinating proteins are then recognized by a plethora of effector proteins with 
ubiquitin-binding domains (UBD) which bind non-covalently through the various surface 
patches of ubiquitin for various further processing (Clague, Liu, & Urbe, 2012; Hershko 
& Ciechanover, 1998; Rahighi & Dikic, 2012). DUBs enable tight regulation of the 
ubiquitin signaling events (Hershko & Ciechanover, 1998).   
Polyubiquitylation 
 
Ubiquitin binds a substrate classically through covalent attachment of it’s C-
terminal carboxylate group to a target lysine. Ubiquitin, an 8.5kDa, 76 amino acid long 
protein, can also be a substrate for ubiquitin binding, as seven amino acids in the 
sequence of ubiquitin are a lysine. 
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Ubiquitylation has many different forms. The seven lysines K6, K11, K27, K29, 
K33, K48, and K63 as well as an amino-terminal methionine are all potential substrates 
for ubiquitylation, and successive addition of ubiquitin by E1, E2, and E3 enzymes, 
collectively referred to as polyubiquitylation, result in ubiquitin chains varying in length, 
topology, and proximal moiety (the lysine of chain origin). All seven lysines reside on 
different surfaces of ubiquitins tertiary structure (Figure 3). 
Each of the polyubiquitin moieties form unique overall structure among the 
continuous ubiquitin-ubiquitin linkages. Polyubiquitylation chains form endogenously in 
homogenous chains (e.g. all K48 linkages) with heterogeneous chains being currently 
speculative. All linkage types are thought to exist within all cells at various abundances 
(Pickart & Fushman, 2004; Y. Wang, Tang, Wang, & Wang, 2014).  Approximately half 
of the populated linkage types are K48 and K63.  
Lysine 48 Polyubiquitylation Chains and Degradation 
In 1989, a ubiquitin chain with distinct topology of isopeptide bonds on K48 was 
discovered, and the poly-ubiquitylation chain was proposed to bind a substrate to the 
proteasome (later shown to be the 26S proteasome) and be essential for its degradation 
(Chau et al., 1989). Polyubiquitylation at K48 is well characterized as a molecular tag for 
degradation by the 26S proteasome.  Destruction is carried out by proteolysis of a protein 
tagged by a lysine chain of at least four (Thrower, Hoffman, Rechsteiner, & Pickart, 
2000) tightly packed, compact globular conformation which the proteasome recognizes, 
removes the ubiquitin for recycling, and ubiquitylated peptides are permitted to enter the 
barrel-shape structure where the central proteolytic core chops the protein into smaller 
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peptides of 3-25 amino acids (Hershko & Ciechanover, 1998). These oligopeptides are 
then released into the cytoplasm or nucleoplasm and can be further digested to single 
amino acids by various soluble peptidases (reviewed in (Korolchuk, Menzies, & 
Rubinsztein, 2010)). 
Intriguingly, ubiquitylation can also target substrates for degradation by 
autophagy-lysosome destruction, a degradation signaling pathway often thought to 
provide bulk, nonspecific degradation (including entire organelles) (Ciechanover, 2005). 
Autophagy is a vesicular trafficking pathway limited to the cytoplasm and capable of 
degrading a wider spectrum of substrates than a proteasome. Although little mechanistic 
similarities occur, these two pathways of degradation share the ability to degrade soluble, 
unfolded polypeptide chains (Ding & Yin, 2008). In the 1990s it was discovered that 
lysosomes can degrade proteasomal subunits (Cuervo, Palmer, Rivett, & Knecht, 1995), 
causing autophagy-lysosome degradation to be hypothesized as a means of controlling 
cellular concentration of proteasomes (Korolchuk et al., 2010).  
During selective autophagy, like the ubiquitin-proteasome system, it is 
ubiquitylation that tags a target for degradation. Unlike the UPS, however, substrates 
recognized for autophagy-lysosome degradation are signaled through K63 
polyubiquitylation chains (Welchman, Gordon, & Mayer, 2005). 
Lysine 63 Polyubiquitylation Chains 
Ubiquitin-conjugates with K63 chains were originally reported in the mid-1990s 
(Galan & Haguenauer-Tsapis, 1997; Spence, Sadis, Haas, & Finley, 1995). K63 
polyubiquitin chains, although also capable of lysosomal and proteasomal degradation 
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signaling, (Saeki et al., 2009), are well defined to contribute to a variety of cellular events 
including DNA repair, signal transduction, receptor endocytosis, and kinase activation 
(reviewed in (Chen & Sun, 2009)). K63 branches were demonstrated to facilitate and 
stimulate endocytosis (Galan & Haguenauer-Tsapis, 1997). Although K63 can catalyze 




In contrast to K48 and K63, the cellular roles of atypical polyubiquitylation  e.g. 
K6, K11, K27, K29, K3, and M1  have yet to be clearly elucidated (reviewed in (Kulathu 
& Komander, 2012)). K29 branches have been detected in yeast and mammals, and can 
be generated in vitro, but little is known regarding any bio functional signaling 
(Kristariyanto et al., 2015). K11 branches have been shown to provide signals for control 
of the cell-cycle and innate immune response (Castaneda, Kashyap, Nakasone, Krueger, 
& Fushman, 2013; Matsumoto et al., 2010; Rape, 2010; Wickliffe, Williamson, Meyer, 
Kelly, & Rape, 2011; Wu et al., 2010). In addition to internal lysines, the amino-terminal 
methionine of ubiquitin can also be a substrate for ubiquitylation. These M1 linkages, 
assembled by the linear ubiquitin assembly complex (LUBAC) are involved with diverse 
signaling processes that are not yet clearly defined (reviewed in (Rieser, Cordier, & 




Figure 1:3 Ubiquitin and its lysine residues. The ribbon model of ubiquitin structure 
highlights the seven lysines residing on different surfaces of its tertiary structure. The 
linking point in linear chains, M1, is spatially close to K63. Red numbers in parenthesis 
indicate relative abundance detected in s cerevisiae.  
Image obtained with permission from work originally published by David Komander. The emerging 
complexity of protein ubiquitination. Soc. Trans. 2009;37:937-953. © The Biochemical Society. 
Monoubiquitylation 
Although polyubiquitylation remains the forefront for ubiquitylation research, 
monoubiquitylation is also biologically significant for DNA repair, viral budding, and 
endosomal sorting. Monoubiquitylation, like K63 polyubiquitylation, can also signal 
endocytosis of membrane proteins.  Monoubiquitylation can also work in conjunction 
with other PTMs to direct the localization of proteins to particular cellular compartments 
(Hicke, 2001; Mosesson & Yarden, 2006). Recent MS studies designed to identify the 
types of ubiquitin chains on ubiquitylated proteins have revealed that monoubiquitin is 
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more common than previously assumed. Using anti-K-ε-GG antibodies, one study 
extended the ubiquitin-modified proteome (ubiquinome) by identifying ~19,000 ubiquitin 
binding sites of ~5,000 proteins (originally determined to be 1,075 proteins with 100 
sites) while also reporting that the majority are subject to non-degradation signaling 
ubiquitylation (W. Kim et al., 2011; Peng et al., 2003). During the same year, another 
study demonstrated that ~ 50% of conjugated ubiquitin is bound to substrates as mono or 
multiubiquitin (Ziv et al., 2011). 
Outside of the nucleus, monoubiquitylation serves to direct endocytosed, 
modified proteins to specific subcellular locations (reviewed in (Haglund, Di Fiore, & 
Dikic, 2003)) and endocytic regulators themselves also undergo monoubiquitylation that 
work to couple substrate recruitment to the ubiquitylation reaction (coupled 
monoubiquitylation) through use of their ubiquitin binding domains (Polo et al., 2002; 
Woelk et al., 2006).  However, a growing body of literature shows that 
monoubiquitylation can also be directly involved in the endocytic trafficking of 
membrane proteins such as ROMK1, which has been reported to decrease surface but not 
total expression following channel monoubiquitylation (Lin et al., 2005). Altogether, 
ubiquitylation can modulate membrane proteins in a variety of ways, including endocytic 
trafficking. Consequently, like protein kinases, the enzymes responsible for catalyzing 
ubiquitylation have important roles in regulating protein function. 
E3 Ubiquitin Ligase Structure and Function 
Ubiquitylation is catalyzed by the sequential action of three enzymes collectively 
referred to as E1, E2, and E3 in a three step process where the reaction catalyzed by each 
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enzyme involves the transfer of a covalent bond with ubiquitin to either the next enzyme 
or, finally, the substrate. E1 ubiquitin-activating enzymes utilize ATP-Mg2+ to charge and 
form a thioester bond with ubiquitin. Charged ubiquitin is then subsequently passed along 
to a second E2-conjugating enzyme and finally the carboxy-terminus of ubiquitin forms 
an isopeptide bond with the lysine of a protein substrate. During this process, E3-
ubiquitin ligases provide the substrate recognition for ubiquitylation. E3s recruit E2s, 
recognize the substrate, and directly catalyze or assist the transfer of ubiquitin from E2 to 
the substrate. The human genome encodes one E1, about 40 E2, and around six hundred 
E3 enzymes (W. Li et al., 2008). In humans, the over 600 E3 ligases are categorized into 
4 groups based of their structural motif:  HECT-type, RING-finger-type, U-box-type or 
PHD-finger-type, with HECT and RING being the two major types of E3’s in eukaryotes 
(reviewed in (Hou & Deng, 2015; W. Li et al., 2008; Nakayama & Nakayama, 2006)). 
Although four structural categories exist, E3 ubiquitin ligases are generally classified into 
two families, HECT-type or RING-type, based on their function. HECT-type E3s have a 
conserved cysteine residue that accepts ubiquitin from E2~Ub forming an E3~Ub 
thioester. Ubiquitin is then transferred from this covalent E3 intermediate to substrate in 
contrast to RING-type E3s which catalyze the direct transfer of ubiquitin from E2~Ub to 
substrate (Figure 4).  
HECT-type Ubiquitin Ligases 
 Homologous to the E6-AP Carboxyl Terminus (HECT)-type ubiquitin ligases 
consist of a small class of E3 ligases which share C-terminal HECT domains that are 
functionally similar to the cellular protein E6-AP (or UBE3A), the E6 protein of the 
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cancer-associate human papillomavirus type 16 and 18 which targets p53 for degradation 
by ubiquitylation. HECT E3s covalently bind ubiquitin by a cysteine residue in the 
catalytic domain and shuttle it onto the target substrate (Huibregtse, Scheffner, 
Beaudenon, & Howley, 1995). The HECT domain is composed of an N-terminal lobe for 
E2 binding and a smaller C-terminal lobe that contains the catalytic cysteine for ubiquitin 
accepting. A flexible hinge region lies between the N- and C- terminal lobes that bridges 
the lobes and allows E2 and E3 catalytic sites to be brought close together during 
shuttling of the ubiquitin (Maspero et al., 2011). Only 28 human HECT-type ubiquitin 
ligases exist and the vast majority of ligases belong to the RING type. 
RING-type Ubiquitin Ligases 
Most E3 ligases belong to the RING family. Really Interesting New Gene (RING) 
based E3 ligases, originally described in 1991 (Freemont, Hanson, & Trowsdale, 1991) 
are encoded by over 600 human genes (human kinases are limited to 518 genes) and 
comprise one of the largest enzyme families. RING-type E3 ligases share a common 40-
60 amino acid RING domain which bind two zinc atoms to zinc-binding “fingers” 
(reviewed in (Callis, 2014; Deshaies & Joazeiro, 2009)). RING domains bind E2s and 
promote a direct transfer of ubiquitin to substrate. Unlike HECT domain E3 ligases, 
RING domain containing ligases do not involve an E3-linked ubiquitin thioester 
intermediate. Bi-substrate enzyme RINGs bind the reactants E2~Ub and substrate, in no 
precedented order, produce products E2 and substrate~Ub with a Michaelis complex 
intermediate. For further ubiquitylation, however, the E2 must be released to allow a 
fresh E2~Ub to bind, as E2s cannot be recharged due to the overlapping binding surfaces 
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of E1s and E3s. Polyubiquitylation by RING E3s starts with a slow, chain initiation step 
followed by a fast, chain elongation step. Unlike conventional bi-substrate enzymes, 
which bind both reactants in close proximity to facility the reaction, E3s bind a substrate 
and E2~Ub up to 50 Angstroms apart, suggesting conformational changes likely occur to 
bring the two reactants closer together for facilitation of the reaction. Ubiquitylation by 
RING E3s, like nearly every biological process, is regulated by phosphorylation, through 
effects on the substrate, E2, or E3 itself. Substrate phosphorylation is the most common.   
Many Cullin-RING ligase substrates such as Skp-1Culin-F-box (SCF) must be modified, 
typically by phosphorylation, in order to bind an E3 and undergo ubiquitylation.  Others, 
such as Anaphase-promoting complex/cyclosome (APC/C)-Cdc20 are activated by 
phosphorylation via direct phosphorylation to the E3 allowing tighter binding of the 
Cdc20 adaptor.  Additionally, binding of APC/ to adaptor Cdh1 during mitosis is 
inhibitory as phosphorylated Cdh1 is unable to bind APC/C.  Altogether, phosphorylation 




Figure 1:4 Cartoon highlighting ligation of ubiquitin to a substrate protein by 
HECT or RING E3 ligases.  A. HECT E3 ligases form a covalent bond with ubiquitin 
and a cysteine within their catalytic domain prior to shuttling ubiquitin to the substrate. B. 
Ring E3 ligases bind E2s and promote a direct transfer of ubiquitin to substrate. 
Image obtained with permission from work originally published by Kazuhiro Iwai. Trends in Cell Biology.  
Diverse ubiquitin signaling in NF-kB activation 2012; 22(7):355 –364.  
 
Ubiquitin Ligase Tripartite Motif-containing Protein 32  
Tripartite motif-containing protein 32 (Trim32) is part of the Trim/RBCC protein 
super family that contributes to various biological signaling including growth, apoptosis, 
cell cycle regulation, muscular physiology, viral and innate immune response, and cancer 
(Hatakeyama, 2011; Ikeda & Inoue, 2012). Trim proteins contain the tripartite/RBCC 
motif composed of a RING domain, one or two B-box domains, and a coiled-coil domain 
(Figure 5) (Meroni, 2012). Trim32 is further subcategorized as a Trim-NHL protein due 
to six C-terminal asparagine, histidine, and lysine (NHL) amino acid repeats that function 
as protein-protein binding domains (Schwamborn, Berezikov, & Knoblich, 2009). Trim-
NHL proteins have been shown to regulate expression of microRNAs (miRNA), small 
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noncoding RNAs that regulate gene expression post-transcriptionally, and thus ultimately 
provide translational control of certain proteins (Loedige & Filipowicz, 2009; Wulczyn, 
Cuevas, Franzoni, & Rybak, 2011).  Trim32 specifically interacts with AGO1 (via its 
NHL domain) and activates miRNA let-7a to promote differentiation in mouse progenitor 
cells (Schwamborn et al., 2009).   
 
Figure 1:5 Schematic of Trim32 structure and sites of disease-associated mutation. 
RING domain provides E3 ligase function of Trim32.  NHL repeats are locations of 
protein interaction and microRNA activation. P130S mutation within the BBOX domain 
causes BBS, while various mutations with the NHL repeats cause LGMD2A. I 
Image adapted with permission from work originally published by Matthew Locke et al. Hum. Mol. Genet. 
TRIM32 is an E3 ubiquitin ligase for dysbindin 2009; 18:2344-2358. 
Trim32 Ubiquitin Ligase Functionality 
The RING domain of Trim32 provides ubiquitin ligase catalysis. Several proteins 
have been reported as substrates for Trim32 catalyzed ubiquitylation: Trim32 can 
ubiquitylate actin in vitro and decrease endogenous actin in HEK293 cells (Kudryashova, 
Kudryashov, Kramerova, & Spencer, 2005), ubiquitylate Abl-interactor 2 (Abi2) in vitro 
and promote degradation in HEK293T (Kano, Miyajima, Fukuda, & Hatakeyama, 2008), 
bind and promote polyubiquitylation and potential degradation of dysbindin in HEK293 
cells (Locke, Tinsley, Benson, & Blake, 2009) and catalyze ubiquitylation of Piasy in 
vitro to promote its destabilization and degradation (Albor et al., 2006). All of these 
examples show Trim32 is able to catalyze ubiquitylation of particular substrates, either 
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directly by using purified recombinant proteins in vitro where Trim32 is the only E3 
ligase present, or overexpression in heterologous systems, in both cases monitoring 
electrophoretic shifts by Western blot. Tools that can demonstrate ubiquitylation of a 
substrate by Trim32 or any E3 ligase directly in tissue are currently limited. 
Trim32 Contributes to the Pathology of Human Disease 
The ubiquitin system has been implicated in the pathogenesis of many diseases 
and genetic disorders. Human neurological disorders appear to be particularly vulnerable 
to mutations in ubiquitin ligases (Kessler, 2013). Mutation of the Trim32 gene causes 
several disease states. Various point mutations within the NHL repeats D487N (third 
NHL repeat), R394H (first NHL repeat), T520TfsX13 (fourth NHL repeat), and D588del 
(fifth NHL repeat) are reported to cause LGMD2H (Locke et al., 2009). In addition to 
LGMD2H, D487N mutation also causes the more severely debilitating sarcotubular 
myopathy (Schoser et al., 2005).   
Trim32 in the Adult Brain 
Trim32 has been studied primarily with respect to pathologies arising from its 
effects in non-neuronal tissue. Although Trim32 is primarily known to cause disease 
states with phenotypes localized to skeletal muscle, Kudryashova et al. in 2009 observed 
that brain Trim32 exceeds muscle Trim32 by over 100 fold and concluded that Trim32 
must have a novel role in the nervous system (Kudryashova, Wu, Havton, & Spencer, 
2009). A mutation within the B-box domain (P130S) causes an unrelated disease Bardet-
Biedl Syndrome (Chiang et al., 2006) that has both physical and neurological deficits. 
Additionally, increased expression of Trim32 has been reported in the occipital lobe of 
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Alzheimer’s disease patients (Yokota et al., 2006), while Trim32 null mice have 
abnormal neurofilament accumulation (Kudryashova et al., 2009)- a symptom of various 
neurodegenerative diseases (Q. Liu et al., 2004). Finally, Trim32 genetic disruption has 
been identified as a risk factor for Autism Spectrum Disorders (ASDs), Attention Deficit 
Hyperactive Disorder (ADHD), and other neurodevelopmental disease (Lionel et al., 
2014).  
Voltage-gated Potassium Channel 1.2 
 
Membrane Potential of Excitable Cells 
 
Electrical activity of biological organisms is driven, for the most part, by ions. 
Living cells are enclosed within a plasma membrane (PM), a semi-permeable lipid 
bilayer structure that separates the extra- and intra-cellular space and prevents ions from 
freely passing into the cell. The unequal separation of charged ions and other molecules 
across the PM generates gradients of both chemical concentration and electrical potential, 
collectively referred to as the electrochemical gradient, and a driving force is produced 
for the ions to cross the PM. In electrical cells, the difference in electrical potential across 
the PM of a quiescent cell, called the resting membrane potential, is driven primarily by 
Na+ and K+ ions. At a resting membrane potential, a cell is in a steady state of continuous 
passive influx of Na+ and efflux of K+ through resting channels that are counterbalanced 
by Na+-K+ pumps utilizing ATP to pump the ions against their respective gradients. The 
unequal positive outward flux caused by Na+-K+ pump (3 Na+ out, 2 K+ in/ ATP) 
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generates a general hyperpolarization of the PM as the interior is negative relative to the 
exterior. 
Ion channels embedded within the PM gate the passage of ions across the 
membrane. Various factors can trigger the opening of ion channels that allow ions to pass 
across the PM down their concentration gradients. In the case of K+, where greater 
amounts of K+ reside in the cytoplasm at rest, opening of these channels results in a loss 
of positive charge within the cell which increases the negativity of the membrane 
potential and hyperpolarizes the cell making it less excitable. Similarly, opening of Na+ 
channels causes an opposite influx of Na+, increased positive charge, and depolarization 
to the membrane. As Na+ influx is a major force for depolarization and generation of 
action potentials, K+ efflux counterbalances and limits depolarization.  
Overview of Voltage-gated Potassium Channels 
 
Neurons communicate with each other through action potentials (AP) that involve 
major alterations in membrane potential. Changes to membrane potential can trigger 
opening of certain ion channels, and if a membrane reaches a certain threshold of 
depolarization, an action potential is generated whereby voltage-gated sodium (Nav) 
channels open to allow the rapid influx of Na+ ions followed quickly by voltage-gated 
potassium channels (Kv) opening to allow efflux of K+ and repolarization of the 
membrane. Potassium channel opening at the PM drive the membrane potential towards 
that of the equilibrium potential of potassium which, in most neurons, causes a 
hyperpolarization that oppose excitation. At resting membrane potential, the majority of 
Kv channels are closed until a depolarization threshold is reached, which triggers the 
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channels to open and repolarize the membrane potential. Thus, some Kv channels return 
depolarized cells to resting state following an AP. Some Kv channels, however, are open 
at sub-threshold voltages and provide major contribution to the resting membrane 
potential. 
General Categorization and Structure of Voltage-gated Potassium Channels 
 
Kv channels are divided into subfamilies originally described by genes Drosphila 
as Shaker, Shab, Shaw, and Shal and correspond to the alpha subunit classifications of 
Kv1, Kv2, Kv3, and Kv4, respectfully in vertebrates (Salkoff et al., 1992). Channels 
encoded by Shaker, Shal, Shab, and Shaw express currents with different biophysical 
properties. Unlike Drosphila, which has only one member per subfamily, the mammalian 
genome contains subfamily genes of Kv channels such as Kv1 which ranges from Kv1.1 
to Kv1.12. Structurally, Kv channels are transmembrane channels that tetromerize to 
form the functional channel. Kv channels may be homotetramers, and also, in the case of 
Kv1, Kv7, and Kv10 families, heterotetramers formed by different alpha subunits within 
the same family (with only a few exceptions of different family member tetramerizing) 
with their own unique channel properties (reviewed in: (Gutman et al., 2005)). 
Additionally, within the same cell, different Kv channels can localize to different cellular 
components for specific functionality (Southan & Robertson, 1998). Several Kv1 
channels activate at subthreshold voltage in many excitable cells where they can 
contribute to the regulation of cell excitability (Bekkers & Delaney, 2001; Dodson, 
Barker, & Forsythe, 2002; Shen, Hernandez-Lopez, Tkatch, Held, & Surmeier, 2004). 
Kv1.2 is one such channel. 
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Overview of Kv1.2 Structure and Function 
 
Kv1.2 provides a major contribution to the resting membrane potential of certain 
excitable cells. Kv1.2 channels can be activated at subthreshold potentials, with reported 
half activation values ranging from -40mV to +30mV (Rezazadeh, Kurata, Claydon, 
Kehl, & Fedida, 2007) and are therefore considered low-voltage-activated channels that 
can open at resting potential or by small depolarization (Al-Sabi, Kaza, Dolly, & Wang, 
2013). These channels are also rapidly activated. 
As with all Kv channel alpha subunits, several functional domains exist within 
Kv1.2: the T1 tetramerization domain within the N-terminus, six transmembrane domains 
(S1-S6), including the S4 voltage-sensing domain, and a potassium selective pore 
between S5 and S6, extracellular domains, and a C-terminus. Both the N and C termini 
provide multiple sites for PTM (Mathie, Wooltorton, & Watkins, 1998).  
Post-translational Modification Regulates Kv1.2 
Like many proteins, Kv1.2 is subject to post-translational modification. N-linked 
glycosylation on the first extracellular loop of Kv1.2 is involved in the trafficking of 
newly translated Kv1.2 (Shi & Trimmer, 1999; Zhu et al., 2003). Fully maturated Kv1.2 
at the PM is subject to phosphorylation. Tyrosine phosphorylation of Kv1.2 suppresses 
channel current and causes down regulation (X. Y. Huang, Morielli, & Peralta, 1993).  
Current suppression by tyrosine phosphorylation has been shown to occur by channel 
endocytosis (Nesti, Everill, & Morielli, 2004). Additionally, serine phosphorylation of 
Kv1.2 have also been reported and suggested to impact Kv1.2 surface expression and 
trafficking of Kv1.2 (J. W. Yang, Vacher, Park, Clark, & Trimmer, 2007; Connnors et al., 
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2007). It should be noted that post-translational modifications of Kv1.2 could also be 
changing channel properties, such as gating, which could in turn alter channel function. 
Indeed, this has been shown to occur with many ion channels including Kv1.2 (Huang et 
al., 1993), but remains an entirely separate topic of investigation outside the scope of this 
work. 
Kv1.2 in the Brain  
Kv1.2 is abundantly expressed in the nervous system and can be found residing 
throughout different critical compartment of a neuron (Dodson et al., 2002; Glazebrook et 
al., 2002; Goldberg et al., 2008; Kole, Letzkus, & Stuart, 2007).  In dendrites, where 
outside information is conveyed into a neuron, Kv1.2 is localized in cerebellar Purkinje 
cells (Khavandgar, Walter, Sageser, & Khodakhah, 2005) and hippocampal pyramidal 
cells (Sheng, Tsaur, Jan, & Jan, 1994) to oppose dendritic depolarization. Summated 
dendritic input can depolarize a neuron to a threshold capable of generating an action 
potential, and Kv1.2 in the neuronal soma such as sensory neurons (Andrews & Kunze, 
2001) and striatal medium spiny neurons (Shen et al., 2004) can oppose this process as 
well.  Kv1.2 can also be found Axon Initial Segment that contribute to the generation and 
shaping of an AP (Lorincz & Nusser, 2008), as well flanking domains called 
juxtaparanode where they modulate axonal excitability by preventing recurrent nodal 
excitation (Rasband et al., 1998; Vabnick et al., 1999). Kv1.2 also is found at axonal 
branch points in some neurons, particularly inhibitory interneuron basket cells (Tan & 
Llano, 1999; Zhang, Messing, & Chiu, 1999).  Altogether, Kv1.2 is abundantly expressed 
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within the mammalian central nervous system where it can provide regulation of neuronal 
excitation. 
Exploring Kv1.2 Regulation in the Brain 
Kv1.2 regulates neuronal excitability throughout the brain. As with cultured cells, 
modulation of Kv1.2 expression in neurons regulate its influence on excitability. For 
example, regulation of Kv1.2 in the cerebellum has important consequences for 
cerebellar function, affecting not only PC dendritic excitability but cerebellum-dependent 
associative learning as well (Williams, Fuchs, Green, & Morielli, 2012). Kv1.2 function 
can be modulated by endocytic trafficking triggered by protein-protein interaction in 
cultured cells (Hattan, Nesti, Cachero, & Morielli, 2002; Williams, Markey, Doczi, & 
Morielli, 2007), however the mechanisms governing Kv1.2 trafficking in the brain 
remain largely unknown.   
Given the criticality of Kv1.2 in the central nervous system, defining modalities 
for Kv1.2 modulation endogenous to the brain may provide valuable insight toward 
understanding fundamental neuronal processes. Studies performed in isolated culture 
systems have generated the majority of known regulatory mechanisms of Kv1.2 in the 
past, however advancements in proteomics allow investigation of proteins in the native 
tissue context more plausible. By starting with an unbiased proteomic approach, novel 
protein interactions and post-translational modifications of Kv1.2 can be readily detected 
from tissue. Such proteomic output can then be further tested in model-systems to 




The preceding literature review provided background information intended to 
supplement the data presented in the manuscripts of Chapters 2 & 3. For both projects, 
the conceptual framework was based off initial MS experiments which detected both 
PTMs and protein associations with Kv1.2 purified from cerebellar extracts that were 
previously unidentified. In Chapter 2, cross-talk between protein ubiquitylation and 
phosphorylation was examined in regard to regulation of Kv1.2 by the ubiquitin ligase 
Trim32. In Chapter 3, regulation of Kv1.2 by the atypical WNK and closely related 
SPAK kinases was investigated. Both studies present potential mechanisms of novel ion 
channel and perhaps neuronal excitability regulation in the cerebellum and further 
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Trim32 is ubiquitously expressed throughout the nervous system, however 
functional roles for the ubiquitin ligase in the developed brain are not well understood. 
Here, using mass spectrometry, we report that Trim32 associates with Kv1.2, an ion 
channel critically involved with establishing and maintaining membrane excitability in 
neurons. Using immunofluorescence we show that Trim32 co-localizes with Kv1.2 to 
regions within the cerebellum. In vitro ubiquitylation assays demonstrated that Trim32 is 
catalytically equipped to ubiquitylate Kv1.2. Using co-expression of Kv1.2 and Trim32 
in HEK293 cells we show that Trim32 regulates the surface expression of the channel in 
cultured cells by two mechanisms, one ubiquitin-dependent and one not. Finally, using a 
combination of quantitative mass spectrometry, mutagenesis, and flow cytometry, we 
show that the effect of Trim32 on Kv1.2 by both mechanisms involve cross-talk with 
Kv1.2 phosphorylation.  
Introduction 
Protein ubiquitylation is the covalent attachment of the small protein ubiquitin to 
a lysine residue within a target protein, either as single units (monoubiquitylation for one 
or multiubiquitylation for more than one) or as ubiquitin chains (polyubiquitylation). 
Polyubiquitin chains arise by sequential addition of ubiquitin proteins onto a lysine 
within ubiquitin, and the specific lysine targeted produces different chains with distinct 
biological effects. The most understood role of ubiquitylation involves the generation of 
polyubiquitin chains linked at lysine 48 (K48). This type of polyubiquitylation has a 
prominent role in targeting proteins for degradation by the 26S proteasome (Ozkaynak, 
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Finley, & Varshavsky, 1984). Because the polyubiquitylation-proteasome protein 
degradation pathway is by far the most extensively studied, it is not surprising that most 
work investigating the role of ubiquitylation in the brain has focused on this pathway 
(Artinian et al., 2008; Jarome, Werner, Kwapis, & Helmstetter, 2011; Lopez-Salon et al., 
2001; Reis, Jarome, & Helmstetter, 2013; Rodriguez-Ortiz, Balderas, Saucedo-Alquicira, 
Cruz-Castaneda, & Bermudez-Rattoni, 2011). However, recent large-scale proteomic 
assessments of the mammalian ubiquitinome have expanded our understanding of both 
the magnitude and diversity of ubiquitylation within the brain (W. Kim et al., 2011; 
Wagner et al., 2012). Increasingly, evidence indicates that proteasome-independent 
effects, mediated by other types of poly, multi, or monoubiquitylation, can function to 
regulate membrane proteins in a way that is conceptually similar to phosphorylation 
(Haglund et al., 2003; Hicke, 2001; Mosesson & Yarden, 2006). One example is a study 
identifying monoubiquitylation of the Inositol 1,4,5-Trisphosphate Receptor (IP3R) which 
found eleven sights all within the regulatory domains. The authors proposed location-
specific monoubiquitylation as an essential mechanism for non-proteolytic regulation of 
the IP3R (Sliter, Aguiar, Gygi, & Wojcikiewicz, 2011; Sliter et al., 2008). 
Enzymatic transfer of ubiquitin to a protein involves the activity of three enzymes 
(termed E1-E3), with the E3 (or ubiquitin) ligase conferring substrate specificity 
(Hershko et al., 1983). One E3 ligase, Trim32, is highly expressed in mammalian brain 
and skeletal muscle (Kudryashova et al., 2009). Most of what is known about Trim32 
concerns its role in muscle function and disease. Mutations within Trim32 causes Limb-
Girdle muscular dystrophy type 2A (LGMD2H) (Frosk et al., 2002) and the more 
severely debilitating sarcotubular myopathy (STM) (Schoser et al., 2005). Most reported 
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substrates of Trim32 are proteins involved in hereditary skeletal muscle disorders such as 
actin and myosin (Kudryashova et al., 2005), desmin (S. Cohen, Zhai, Gygi, & Goldberg, 
2012), ABL2 (Kano et al., 2008) and PIASY (Albor et al., 2006). In contrast, despite its 
high neuronal expression, Trim32’s molecular targets and roles in the brain are far less 
understood. Two recent studies indicate that Trim32 is involved in complex emotional 
behavior and may have a role in depression and anxiety disorders (Hillje et al., 2015; 
Ruan et al., 2014). Genetic studies have identified links between Trim32 and a range of 
neurological disorders, including Autism Spectrum Disorders (ASD) and Attention 
Deficit Hyperactive Disorder (ADHD) (Lionel et al., 2014). Intriguingly, ASD and 
ADHD linked to Trim32 dysfunction are comorbid with epilepsy, a condition that 
involves neuronal hyper-excitability (Lo-Castro & Curatolo, 2014). Mood disorders, 
ASD and seizure disorder are associated with defects in neurodevelopment, a process 
dependent on Trim32 as a neural stem cell fate determinant (Hillje et al., 2015; Hillje, 
Worlitzer, Palm, & Schwamborn, 2011; Schwamborn et al., 2009). Thus, current models 
focus on neurodevelopment as a primary mechanism for Trim32 effects in the brain.   
However recent studies have identified potassium channelopathies as potential 
contributors to ASD as well (reviewed in (Schmunk & Gargus, 2013)).   
Voltage-gated ion channels are major determinants of neuronal excitability. The 
voltage-gated potassium channel Kv1.2 is expressed widely throughout the nervous 
system, but it is expressed to the highest density within the cortex of the cerebellum 
(McNamara, Averill, Wilkin, Dolly, & Priestley, 1996; McNamara, Muniz, Wilkin, & 
Dolly, 1993; Veh et al., 1995). Its expression there is largely concentrated within 
presynaptic terminals that provide inhibitory input to Purkinje cells (Khavandgar et al., 
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2005; Sheng et al., 1994; Southan & Robertson, 1998) and within Purkinje cell dendrites 
where it influences responses to excitatory input. Because Purkinje cells form the core 
computational unit within the cerebellar cortex, and because they also provide its sole 
output to cerebellar nuclei and ultimately the rest of the brain, Kv1.2, through its effect 
on Purkinje cells, has a uniquely central impact on cerebellar function. This was recently 
underlined by the finding that mutations within Kv1.2 cause a specific type of inherited 
cerebellar ataxia (G. Xie et al., 2010). 
In this study we identify a new role for Trim32 in the cerebellum as a modulator 
of the potassium channel Kv1.2. Using mass spectrometry (MS), we identified Trim32 as 
part of the cerebellar Kv1.2 protein interactome and identified sites of ubiquitylation 
within native cerebellar Kv1.2. These in vivo findings provided the foundation for in vitro 
studies to determine the mechanisms by which Trim32 regulates Kv1.2. We found that 
Trim32 mediates mono-ubiquitylation of Kv1.2 which in turn modulates the channels’ 
endocytic trafficking. Further, we used a quantitative MS approach to show that Trim32 
not only affects channel ubiquitylation, but also influences phosphorylation at two C-
terminal serines (S434 and S440) that lay adjacent to the channel’s primary ubiquitylation 
site (K437), and that phosphorylation at these sites have differential, ubiquitylation 
dependent effects on Kv1.2 trafficking. Therefore, our findings indicate that Kv1.2 
function is determined by inter-dependent effects of ubiquitylation and phosphorylation.  
These findings indicate that Trim32 mediated regulation of Kv1.2 constitutes a potential 




The Ubiquitin Ligase Trim32 Co-purifies with Kv1.2 from Rat Cerebellar Extracts 
The cell surface level of Kv1.2 is governed by a homeostatic balance between 
channel endocytosis from and recycling back to the plasma membrane, a process 
controlled by serine/threonine as well as tyrosine phosphorylation of the channel 
(Connors, Ballif, & Morielli, 2008; Nesti et al., 2004; Stirling, Williams, & Morielli, 
2009). Mechanistic specificity for the regulation of ion channels is conferred to a large 
extent by the composition of an associated macromolecular complex of proteins. Such 
interactions determine the channel’s sub-cellular localization, but also confer bias 
towards regulation by specific signaling pathways (Swayne, Altier, & Zamponi, 2014).  
To identify novel interactions of Kv1.2 within the brain, we examined the interactome of 
Kv1.2 using an unbiased proteomic approach: Kv1.2 was purified from tissue 
homogenates that were separated into non-nuclear membrane fractions prior to lysis. 
Kv1.2 and associated proteins were separated by SDS-PAGE electrophoresis, and 
separated gel bands were subjected to an in-gel digestion with trypsin to produce tryptic 
peptides that were analyzed by liquid chromatography tandem mass spectrometry (LC-
MS/MS). Figure 1A shows a representative gel stained with Coomassie Blue to indicate 
proteins isolated within the appropriate molecular weight range for both Kv1 channels 
and Trim32 following Kv1.2 IP. Cerebellum from two rats (6 week old)  were lysed in 
the presence of protease inhibitors only (HALT cocktail of 100mM AEBSF*HCl, 80µM 
Aprotinin, 5mM Bestatin, E-64, 1.5mM EDTA, 2mM Leupeptin, and 1mM Pepstatin A = 
MS trial 1), protease inhibitors plus DUB and proteasome inhibitors (HALT protease 
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cocktail, 5mM N-Ethylmaleimide, and 10µM MG-132 = MS trial 2), and protease, DUB, 
proteasome, and phosphatase inhibitors (HALT protease cocktail, 5mM N-
Ethylmaleimide, and 10µM MG-132, 1mM NaF, 1mM NaOrthovanadate, and 20mM 
BAPTA= MS trial 3) yielding 20, 17, and 37 total detected peptides of Kv1.2, 
respectively. In all conditions, the ubiquitin ligase Trim32 was detected as a novel 
interacting protein by 3 or more unique tryptic peptides that were never present in 
parallel, nonspecific IP controls (Figure 1B). This interaction was also detected by 
Western blot (WB) analysis, either through IP of Kv1.2 (Figure 1C, left) or Trim32 
(Figure 1C, right), both of which demonstrated Co-IP of the interacting partner in the 
lysis conditions of MS trial 2 and 3. 
Detection of Trim32 from our homogenates was low in the absence of DUB and 
proteasome inhibitors, and likewise co-IP was not detected by IP of either Kv1.2 or 
Trim32 (Supplementary information; Appendix A Figure A:2), suggesting that 
preservation of the association of Trim32 with Kv1.2 may be impacted by enzymes that 
alter ubiquitylation. 
Trim32 Localizes with Kv1.2 in the Cerebellum 
In the brain, Kv1.2 is especially abundant in the cerebellar cortex. The channel is 
expressed post-synaptically in the dendrites of Purkinje cells (PC), the major 
computational entity within the cerebellum, and pre-synaptically in the axon terminals of 
basket cell (BC) interneurons which provide strong inhibitory synaptic input to PCs 
(Southan & Robertson, 1998, 2000). Residing within these two key cerebellar locations, 
Kv1.2 is able to affect both the inhibition and excitation to PCs, the sole output of the 
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cerebellar cortex, and thus influence cerebellar processing to the rest of the brain. Our 
immunofluorescence (IF) analysis revealed that Trim32 is ubiquitous throughout the 
cerebellum (Figure 2). Co-staining with Parvalbumin, a marker for PCs and molecular 
layer interneurons, showed that Trim32 is clearly present in BC soma, cellular origin of 
inhibitory complexes called Pinceau which form a basket-like structure around the axon 
initiation segment of PCs (Figure 2A and B). Imaging at higher magnification showed 
co-localization in the Pinceau more clearly (Figure 2C). In our experiments, Trim32 did 
not always overlap with Kv1.2 due to the extensive expression of Trim32 in locations 
such as the granule layer and PC somas where Kv1.2 is absent. As a multifunctional 
protein enzyme, Trim32 was not expected to exclusively localized with Kv1.2 and these 
images are intended to simply provide evidence that Trim32 and Kv1.2 are simple able to 
be localized in the cerebellum. Analysis was performed using a Deltavision Restoration 
Microscopy System on fixed, permeabilized 50uM thick cerebellar slices and results were 
replicated in two separate experiments. 
Trim32 can Directly Ubiquitylate Kv1.2 in Vitro 
After establishing that Trim32 interacts and localizes with Kv1.2 in the 
cerebellum, we next investigated its functional role on the channel. To determine whether 
Trim32 can directly ubiquitylate Kv1.2, an in vitro ubiquitylation assay using 
recombinant purified GST-fused Trim32 and Kv1.2 variants was performed (Figure 3).  
Kv1.2, in the presence of only E1, E2, Trim32 (E3), ATP, and ubiquitin, is ubiquitylated 
at either it’s C or N terminus (GST-Kv1.2C/GST-Kv1.2N) by Trim32 as determined by 
stepwise ~10kDa molecular weight increases of Kv1.2 (Figure 3B). The reaction was 
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initiated by the addition of ATP to activate ubiquitin. As a control, the reaction was also 
prevented in an identical experiment by withholding ATP alone and, as expected, no 
ubiquitylation was detected. Trim32 self ubiquitylation was additionally used as a 
ubiquitylation confirmation (data not shown). To confirm the electrophetic band shifts 
were not due to ubiquitylation of GST alone, the reaction was repeated with GST cleaved 
Kv1.2C/N and higher molecular weight bandshifts of Kv1.2 were still observed (Figure 
3C), indicating that ubiquitylation is occurring on Kv1.2. 
Kv1.2 is Ubiquitylated in the Cerebellum 
Ubiquitylation of Kv1.2 at two N-terminal lysines (K49 and K63) has recently 
been reported by a single, large scale LC-MS/MS study in the mouse brain (Wagner et 
al., 2012). No sites of Kv1.2 ubiquitylation have been reported in the cerebellum 
specifically. In the same LC-MS/MS experiments that detected the Trim32 interaction 
(Figure 1A), we also detected ubiquitylation of Kv1.2 at C-terminal lysine K437 (Figure 
4). In particular, two peptides of lysine 437 were detected in each of the three MS trials 
(Figure 4C). The previously reported N-terminal lysines were also both detected in one 
of three MS trails (Supplementary Information; Appendix C Figure C:2). Given that 
Trim32 was the only ubiquitin ligase detected by mass spectrometry from cerebellar 
homogenates following Kv1.2 purification, we hypothesize that Trim32 could 
ubiquitylate Kv1.2 there.  
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Trim32 Increases Kv1.2 Surface Expression in HEK293 Cells through a Mechanism 
Dependent on Channel Ubiquitylation. 
Trafficking of Kv1.2 modulates its expression at the surface and therefore overall 
impact on membrane potential (Nesti et al., 2004; Stirling et al., 2009). Recently, we have 
shown that both BC axon termini and Purkinje cell dendrites are locations of AC-
dependent Kv1.2 trafficking (Williams et al., 2012). To date, no modulators of Trim32 
signaling have been reported, limiting in vivo manipulation. However, heterologous 
systems have been valuable tools for investigating Kv1.2 trafficking mechanisms, and 
allow the overexpression of mutated constructs that may prevent or cripple the process of 
ubiquitylation. We therefore next utilized HEK293 cells to determine if Trim32 can 
regulate Kv1.2.  
Kv1.2 function is regulated by its endocytosis from and recycling back to the 
plasma membrane (Nesti et al., 2004; Stirling et al., 2009). To measure changes in 
surface Kv1.2 levels in HEK293 cells we used a flow cytometry assay as previously 
described (Nesti et al., 2004). Figures using this assay depict normalized count as the 
objective measure in which we interpret as surface Kv1.2. Over-expression of ubiquitin 
can drive ubiquitylation of proteins and so we used this method to investigate the effect 
of ubiquitin on Kv1.2 trafficking. We used co-expression with wild-type ubiquitin (WT-
Ub) or with a form of ubiquitin that can only induce monoubiquitylation (lysines within 
ubiquitin mutated to arginine) of substrates (mUb). WT-Ub caused an overall decrease of 
surface channel (-37%, t(df) = 6.65(10), p < 0.0001, n = 6 each) while mUb caused an 
increase (+32%, t(d) = 8.27(10), p < 0.0001, n = 6 each) (Figure 5A). We next 
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investigated the influence of Trim32 on Kv1.2 surface expression (Figure 5B). Like 
mUb, co-expression of wild-type Trim32 caused a significant increase of surface channel 
(+15%, t(df) = 4.56(16), p < 0.001, n = 6 (+vector), n = 12 (+Trim32WT)) (Figure 5B, 
left graph). In cerebellar tissue, K437 is the most prevalent site of ubiquitylation detected 
by multiple LC-MS/MS experiments. We therefore used site directed mutagenesis to 
assess the role of this lysine on Trim32 mediated channel regulation. We found that 
mutation of K437 to alanine (K437A) caused baseline surface Kv1.2 to decrease 
compared to the wild-type channel (-32%, 7.52(16), p < 0.0001, n = 6 (Kv1.2WT), n = 12 
(Kv1.2K437A). Strikingly, this point mutation eliminated the surface Kv1.2 increase seen 
with Trim32 co-expression +0.004%, t(df) = 0.17(22), p = 0.87, n = 12 each). Taken 
together, overexpression of Trim32 appears to cause a significant increase of surface 
Kv1.2 through a mechanism that may involve mono-ubiquitylation at lysine 437, the 
most prevalent site of ubiquitylation detected in cerebellar tissue. 
To determine whether over-expression of Trim32 or mUb involves modification of other 
lysine residues within Kv1.2, we assessed their effect on mutant forms of Kv1.2 that have 
all C and N terminal lysines replaced with arginine (Kv1.2KR). Kv1.2KR dramatically 
attenuated the Trim32 and mUb effects on Kv1.2 trafficking: 2-way ANOVA significant 
main effect of co-expressions (column); F(2, 105) = 52.50, p < 0.0001, and a significant 
main effect of Kv1.2 lysines (row), F(1, 102) = 125.2, p < 0.0001, n = 12 (Kv1.2WT+ 
vector), n = 24 (Kv1.2WT + Trim32), n = 18 (Kv1.2WT + mUb), n = 12 Kv1.2KR, n = 
24 (Kv1.2KR + Trim32), n = 12 (Kv1.2KR + mUb). To test whether the effect of Trim32 
on Kv1.2 was dependent on the ubiquitin ligase activity of Trim32 we used a version of 
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Trim32 lacking its catalytic RING domain (Trim32∆RING). In duplicate experiments we 
found that this version of Trim32 had no effect on Kv1.2 (Figure 5D):1-way ANOVA, 
F(3, 44) = 188.2, p < 0.0001; Kv1.2WT + Trim32WT-Flag (+100%, q(df) = 13.82(44), p 
< 0.0001, n = 12 each), Kv1.2WT + Trim32WT-GFP (+133%, q(df) = 18.40(44), p < 
0.0001, n = 12 each), Kv1.2WT + Trim32∆RING (-5.32%, q(df) = 0.7341(44), p > 0.05, 
n = 12 each. Collectively, these results suggest that Trim32 is able to increase Kv1.2 at 
the cell surface through channel monoubiquitylation.  
As indicated in Figure 3, attachment of the small protein ubiquitin to a substrate 
adds a molecular weight increase (~8.5kDa without FLAG tag) that can be detected 
through electrophoretic bandshifts via immunoblot analysis. We therefore used WB 
analysis to determine whether overexpression of either Trim32 or mUb causes detectable 
changes in the electrophoretic mobility of Kv1.2 expressed in HEK cells (Figure 5E).  
Overexpression of Kv1.2 in HEK cells produces two main bands representing different 
glycosylation states of the channels development (lower = high mannose and higher = 
mature).  In the presence of either Trim32WT or mUb, two clear bands of approximately 
8.5kDa increased molecular weight from the high mannose Kv1.2 appear that is only 
faintly detected in the Kv1.2 only (+ empty vector) transfection (Figure 5B). Total Kv1.2 
had no significant change in three replicate experiments (data not shown). Taken together 
with the flow cytometry data, Trim32 is able to cause detectable monoubiquitylation that 




Trim32 Decreases Kv1.2 Surface Expression Independent of Ubiquitylation of 
Kv1.2 
During the course of this study we observed that the confluence of plated cells 
dramatically impacted the effect of Trim32 on Kv1.2 surface expression. In other 
contexts, Trim32 has been shown to have ubiquitin-independent effects, the most 
understood being the binding of proteins to its NHL repeats for activation of microRNAs 
(Loedige & Filipowicz, 2009; Wulczyn et al., 2011). We therefore asked if the 
confluence-dependent effects that we observed on Kv1.2 might involve ubiquitin-
independent mechanisms. In the following experiments, we utilized cells grown to higher 
confluence (plated at higher density and grown one additional day) simply as a 
representation of a different cellular condition that may demonstrate different signaling 
patterns than that of the lower confluence conditions of the previous experiments. We 
found that in highly confluent cells, Trim32 caused a significant decrease of surface 
Kv1.2 (-32%, t(df) = 8.30(60), p < 0.0001, n = 12 (Kv1.2WT + vector), n = 6 (Kv1.2 + 
Trim32) (Figure 6A, left). MUb, however, continued to cause a significant increase in 
surface Kv1.2 (+18%, t(df) = 4.72(60). As expected, replacing Kv1.2WT with Kv1.2KR 
diminished the Kv1.2 surface increase by mUb (+3.7%, t(df) = 1.20(60), p > 0.05, n = 12 
(Kv1.2KR + vector), n = 12 (Kv1.2 + mUb) however, unlike cells plated at low 
confluence, the effect of Trim32 was unchanged in Kv1.2KR channels (-37%, t(df) = 
11.86(60), p < 0.0001, n = 12 each; mean difference between rows (Kv1.2WT vs 
Kv1.2KR) = 5.29%, p > 0.05; two-way ANOVA significant lysine effect, F(1, 60) = 
11.24, p < 0.0025, significant co-expression factor F(2, 60) = 196.2, p < 0.0001, n = 12 
(Kv1.2WT + vector), n = 6 (Kv1.2 + Trim32), n = 12 (Kv1.2WT + mUb), n  = 
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12(Kv1.2KR + vector), n = 12 (Kv1.2KR + Trim32), n = 12 (Kv1.2KR + mUb). This 
effect was enhanced by replacing Trim32WT with Trim32∆RING (mean difference 
between Kv1.2WT+ GFP-Trim32WT vs Kv1.2WT + GFP-Trim32∆RING = -39%, p < 
0.0001), lending strong support for this being a ubiquitin-independent effect of Trim32 
on Kv1.2 (Figure 6A, right).  
Recent studies have shown that ubiquitylation and phosphorylation can have 
substantial cross talk.  Phosphorylation can promote or inhibit ubiquitylation leading to or 
altering various signaling events (reviewed in (Hunter, 2007)). Additionally, ubiquitin 
ligases can be activated by phosphorylation, and similarly, kinases can be deactivated by 
ubiquitylation (Persaud et al., 2014; Snyder, 2009). We wondered if the presence of 
Trim32 can influence the phosphorylation state of Kv1.2 during high confluence 
conditions. To investigate this, we used the quantitative LC-MS/MS method of Stable 
Isotope Labeling of Cells in Culture (SILAC) to detect quantitative changes of 
phosphorylation following co-expression with Trim32. Kv1.2 was expressed alone 
(+empty vector) in cells cultured in media containing arginine and lysine amino acids 
with light isotopes (K 12C6 & 14N2 and R 12C6 & 14N4), while Kv1.2 was co-expressed 
with Trim32 in cells cultured in media containing arginine and lysine amino acids with 
heavy isotopes (K 13C6 & 15N2 and R 13C6 & 145N4 (Figure 6B). Cells were lysed in buffer 
conditions equivalent to tissue MS trial 3 of Figure 1 and equal protein concentration 
from both light and heavy populations were pooled together prior to electrophoresis. 
Lysates were immunoprecipitated for Kv1.2 and processed for LC-MS/MS exactly as the 
cerebellar homogenates with the addition of reduction (.1M DTT, 30min, 55 degrees C) 
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and alkylation (55mM, 45 minutes RT) iodoacetamide) prior to digestion for proper 
quantification of cysteine containing peptides. 
In agreement with the flow cytometry experiments, no ubiquitylated peptides of 
Kv1.2 were detected in ether the absence or presence of Trim32 in the highly confluent 
cells. Because Kv1.2 is highly phosphorylated at several serine residues adjacent to the 
cerebellar ubiquiylation site K437, we examined whether Trim32 overexpression alters 
these states of phosphorylation. Interestingly, the presence of Trim32 caused a dramatic 
decrease of phosphorylated S434 with a corresponding increase of the non-
phosphorylated S434 peptide (at both +2 (Figure 6C, top) and +3 (not shown) charge 
states), while S440 was unchanged (Figure 6C, bottom). It should be noted that the 
nonphoshorylated peptides of 1048.98 (light) and (1052.99 heavy) m/z were confirmed 
by MS2 fragmentation, however the detected peptides reported here of 1089.00 and 
1093.01 m/z as the phosphorylated versions were not given their overall low abundance 
in the MS1 process and the non-targeted LC-MS/MS approach performed. The peptide 
m/z was in agreement with previous reports of the same peptide (Yang et al., 2007) as 
well as previous LC elution retention times previously detected by our lab (data not 
shown). In all of our experiments in tissue and cultured cells, this phosphopeptide was 
always localized to S434 and not nearby T433. 
Like K437 ubiquitylation, S434 and S440 phosphorylation are consistently 
detected in cerebellar tissue. We investigated if these modification sites, like K437, have 
a role in surface trafficking of the channel in HEK cells. To avoid compensation by 
nearby T433 and S441 (and account for potential ambiguity of LC-MS/MS spectra 
matching), we compared Kv1.2WT to Kv1.2T433V/S434A and Kv1.2S440A/S441A 
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double mutants. In cells plated to low confluence, Kv1.2T433V/S434A mutation caused a 
dramatic reduction in surface Kv1.2 (-80%, q(df) = 17.92(47), p < 0.0001, n  = 6 each). 
Kv1.2S440A/S441A had a more subtle but significant decrease of surface Kv1.2 
compared to the wild-type channel alone (-14%, q(df) = 3.25(47), p < 0.001, n = 6 each) 
that was not significant by individual t-test. These results suggest that availability of S434 
(and possibly T433) for phosphorylation may be critical for getting Kv1.2 to the surface 
(the functional role of S434 is unknown). Additionally, adding Trim32 overexpression, 
we see the expected increase of surface Kv1.2, however Kv1.2T433V/S434A amplified 
the effect by 10 fold (mean difference between Kv1.2WT + Trim32 and 
Kv1.2T433/VS434A + Trim32 by 1-way ANOVA multiple comparisons = 151.12%, p < 
0.0001) (Figure 6D, left and middle insert).  Unexpectedly, the Kv1.2S440A/S441A 
mutant, which caused a modest decrease of surface Kv1.2 alone, reversed the effect of 
Trim32 to a significant decrease, suggesting that the increase of Kv1.2 surface expression 
by Trim32 may first require phosphorylation of S440/S441.  
Discussion 
Although historically viewed as a regulator of motor function, a growing body of 
research indicates the cerebellum is essential for a wide range of non-motor functions. 
These include modulation of autonomic function to processing of emotional information 
and other cognitive functions. The link to emotional and cognitive function may be 
especially important for understanding behavioral and cognitive symptoms of autism 
since defects in cerebellar structure are highly correlated with autism (Allen, Muller, & 
Courchesne, 2004; Fatemi et al., 2012; Whitney, Kemper, Bauman, Rosene, & Blatt, 
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2008).  Interestingly, ASD is not typically associated with motor dysfunction, suggesting 
a particularly important role for non-motor cerebellar effects. Genetics studies suggest a 
key role for disruption in cerebellar inhibitory neurotransmission, but the 
neurophysiological mechanisms linking cerebellar function with ASD remain unclear. 
Understanding the neurophysiological roles of autism-related genes, such as Trim32, is 
therefore essential. 
Trim proteins are involved in diverse biological processes throughout the body, 
and Trim32 is no exception. The links of Trim32 mutation to degenerative muscular 
disease led to the magnitude of discovered Trim32 functions within skeletal muscle 
tissue, however more Trim32 resides within the brain than all other organs combined, 
suggesting that Trim32 likely has important neurological roles that are at this time, 
overlooked (Kudryashova et al., 2009). The work in this study proposes a unique and 
exciting role for Trim32 in the adult brain:  From purified cerebellar tissue, we first took 
an unbiased proteomic approach to identify Trim32 as an interacting protein with Kv1.2, 
an ion channel key for regulating neuronal excitability. Next, we used mutagenesis and 
overexpression across both biochemistry and flow cytometry experiments to provide 
evidence that Trim32 regulates Kv1.2’s surface trafficking through multiple mechanisms.   
Trim32’s most understood role is its ubiquitin ligase activity, particularly in 
catalyzing polyubiquitin chains on proteins to signal their degradation by the proteasome.  
Here, we have shown that Trim32 can regulate Kv1.2 in a ubiquitin-dependent but 
degradation-independent mechanisms. In heterologous systems, our data suggest that 
Trim32 increases channel surface expression by a monoubiquitlyation like mechanism. 
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Comparing Trim32 overexpression experiments (both biochemistry and flow cytometry) 
with those of wtUb and mUb, the increased surface Kv1.2 appears to work through mono 
or multiubiquitylation of the channel. Non-degradative trafficking of ion channels by 
mono or multiubiquitylation has been previously reported, however, usually the ubiquitin 
tagged channels are endocytosed into primary vesicles and trafficked to early endosomes 
where ubiquitin is removed by deubiqitinating enzymes (W. H. Wang, 2006). 
Monoubiquitylation of ROMK1 (Kir1.1) decreases its surface but not total expression 
(Lin et al., 2005), while overexpression of an E3 ligase (Nedd4-2) also caused decreased 
surface Kv1.3 and Kv1.5 in Xenopus Oocytes (Boehmer et al., 2008; Henke, Maier, 
Wallisch, Boehmer, & Lang, 2004). Monoubiquitylation is recognized as a sorting signal 
throughout the endocytic pathway, however a mechanism to promote expression at the 
plasma membrane through endocytic trafficking, perhaps by increased recycling, has not 
been reported. Our finding that Trim32 increases surface Kv1.2 is consistent with such a 
mechanism although other mechanisms, including decreased constitutive endocytosis or 
increased biosynthetic trafficking to the plasma membrane are also possible.     
How Trim32 affects Kv1.2 in vivo and what the effects of that are on brain 
function remains unknown. As mentioned previously, large-scale genetic reports have 
determined Trim32 is both a risk factor for ASD/ADHD as well as a genetic link for 
ASD/ADHD comorbid with epilepsy, a disease state with known Kv1 channel 
involvement. A point mutation in Trim32s B-Box domain (P130S) leads to the less 
commonly developed Bardet-Biedl Syndrome (Chiang et al., 2006) that, interestingly, 
some patients with Bardet-Biedl syndrome report cerebellar dysfunction (Keppler-
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Noreuil et al., 2011), including a case of cerebellar ataxia (Kowal & Sikora, 1989), a 
channelopethy that can be caused by KCNA2 (Kv1.2) mutation (G. Xie et al., 2010). The 
findings reported here linking Trim32 with Kv1.2 function suggests novel avenues for the 
development of therapeutics and pharmaceuticals for these diseases. 
Materials and Methods 
Tissue Harvest and Membrane Fractionation 
Cerebellar tissue was harvested from adult (5-9 week) Sprague Dawly rats and 
homogenized in  10 mM HEPES (pH 7.4), 0.3M sucrose, 2mM EDTA, 1mM DTT, 1mM 
NaF, 1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132 and protease 
inhibitors (HALT cocktail of 100mM AEBSF*HCl, 80µM Aprotinin, 5mM Bestatin, E-
64, 1.5mM EDTA, 2mM Leupeptin, and 1mM Pepstatin A) using a 15mL dounce 
homogenizer (10-15 strokes).  Nuclear proteins were removed by low speed spin (1000g 
for 10 min at 4°C) and samples were separated into membrane fractions by 
ultracentrifugation (200,000 for 90 min at 4°C).  The supernatant containing cytosolic 
proteins was discarded and remaining non-nuclear, membrane fraction was then re-
suspended and lysed in 50mM Tris (pH 7.41), 150 mM NaCl, 1mM EDTA, 0.25% 
deoxycholate, 1% NP-40, 1mM DTT, 1mM NaF, 1mM NaOrthovanadate, 20mM 
BAPTA, 5mM NEM, 10 µM MG-132 and protease inhibitors (HALT).    
Co-immunoprecipitation 
Immunoprecipitation (IP) with soluble lysates was performed with magnetic Dynabeads 
(Gibco, 30µl bead/ 1µg antibody) for 1 hr at 4°C.  IPs were washed three times with lysis 
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buffer. Lysates and IPs were analyzed by SDS-PAGE and Western blotting using anti-
Kv1.2 (K14/16 mouse monocolonal, UC Davis, 1.5µg/cerebellum) and anti-Trim32 
(Rabbit polyclonal, GeneTex, 1.5µg/cerebellum) antibodies.  For IPs processed for LC-
MS/MS analysis, proteins were separated by 1D SDS-PAGE electrophoresis and 
visualized with Coomassie staining. 
In Gel Digestion and Mass Spectrometry Analysis 
Coomassie stained gel pieces were excised, diced, washed, destained, dehydrated, and 
digested with 1.25ng/µl trypsin as previously described (Connors et al., 2008)  Extracted 
peptides were analyzed by LC-MS/MS using an LTQ linear ion trap mass spectrometer 
alone or as a LTQ-Orbitrap hybrid mass spectrometer (SILAC).  Identification of post-
translational modifications included dynamic modification of 79.96 to S/T/Y and 
114.0429 to K amino acids.  A detailed description of mass spectrometric conditions are 
presented in the Extended Experimental Procedures. 
Immunofluorescence 
Cerebellar/hippocampal slice images:  Adult rat cerebellar slices (50 µM) were fixed (2% 
formaldehyde cardiac perfusion), permeabilized (0.2% Triton X-100), blocked, and 
stained for Kv1.2 (1:200) and Trim32 (1:100), and imaged using a DeltaVision 
Restoration Microscopy System (Applied Precision).  Images were acquired 20X, 60X, or 
100X oil immersion lenses using the SoftWorks software and analyzed with NIH Image 
J.  Colocalization was determine using the Colocalization Point plugin using automated 
threshold detection that was manually verified.   
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In Vitro Ubiquitylation Assay 
Purified recombinant FLAG-ubiquitin, ubiquitin-activating enzyme (E1), and E2 
ubiquitin-conjugating enzymes (UbcH5a) were purchased from Boston Biochemical. 
GST-Trim32 was expressed in E. coliBL21(DE3)pLysS strain (Stratagene), and isolated 
from cells lysed in 10 mMTris/HCl, pH 8.0, 10% glycerol, 1% Triton X-100, 100 mM 
NaCl, 10 mM MgCl2, 10 µM ZnCl2, and protease inhibitors using glutathione-Sepharose 
4B beads in bulk suspension. Prior to use, Trim32 was released from the GST-bead 
complex with thrombin in buffer containing 50 mM Tris, 5 mM MgCl2, 100 mM NaCl, 1 
mM DTT and 0.5. In vitro ubiquitination reactions were done by combining FLAG-
ubiquitin, E1 and E2 (UbcH5a) ligase, ATP and Trim32 in 50 mM Tris/HCl, pH 8.0, 5 
mM MgCl2, and 0.5 mM dithiothreitol. Reactions were incubated at 37 °C for 120 min 
and stopped by heating to 100 °C in protein sample buffer. 
Cell Culture and Flow Cytometry 
Kv1.2 was overexpressed in HEK293 cells stably expressing the beta subunit HEKβ2. 
For detection of cellular surface expression, an antibody that binds an external portion of 
Kv1.2 was used for fluorescent detection by flow cytometry as previously described 
(source).  For high confluence detection, cells were allowed to grow for an additional 1-2 
days following transfection. 
SILAC Mass Spectrometry 
Culture media in the Light population contained lysine and arginine amino acids with K 
= 
12C6 & 14N2 and R = 12C6 & 14N4) while Heavy populations contained them with K = 
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13C6 & 15N2 and R 13C6 & 15N4. Cells were grown to full confluence and split 5 times in 
respective media before plating for transfection. In repeat experiments, the Light 
population was overexpressed with Kv1.2 + empty vector and the Heavy population with 
Kv1.2 + Trim32.   
 
Supplementary Materials 
Supplementary material can be found in Appendix A. 
Figure Legends 
 
Figure 1.  The ubiquitin ligase Trim32 interacts with Kv1.2 in the cerebellum. A.)  
Coomassie stained gel showing successful immunoprecipitation of proteins in the 
predicted range of neuronal Kv1 channels (~90kDa) and Trim32 (65-100kDa). B.)  
Trim32 can be detected by LC-MS/MS after immunoprecipitation of Kv1.2 from rat 
cerebellum tissue. Throughout multiple experiments, no Trim32 peptides were detected 
in parallel IgG antibody control IPs. C.) The Trim32 interaction with Kv1.2 in cerebellar 
tissue can also be detected by Western blot co-IP analysis. Left:  WBs showing IP of 
Kv1.2 (top) with corresponding Trim32 Co-IP (middle) and lysate (bottom) confirming 
both proteins.  
 
Figure 2 Trim32 is expressed in cerebellar localizations with Kv1.2.  A.) Cartoon 
depiction of cells within the cerebellum and localizations of Kv1.2. B.) Trim32 is diffuse 
throughout the cerebellum as examined immunofluorescence at 10X magnification (data 
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not shown). Closer examination (60X) with co-staining of Parvalbumin (yellow), a 
marker for molecular layer neurons and PCs, show Trim32 is found within BCs. C.) 
Kv1.2 is of highest expression in BC pinceaus structures, and high magnification (100X) 
show Trim32 also localizes to these structures. 
 
Figure 3.  Trim32 can directly ubiquitylate Kv1.2 in vitro.  A.) Schematic image of the 
in vitro ubiquitylation reaction.  Recombinant purified E1, E2 and Trim32 (E3) proteins 
were combined with a recombinant purified GST-fusion protein of the C or N-terminus 
of Kv1.2 (GST-Kv1.2N/C). The ubiquitylation reaction was initiated by addition of ATP.  
B.) Immunoblot analysis shows incremental upward shifts in electrophoretic mobility of 
GST-Kv1.2N/C indicative of the increased molecular weight conferred by covalent 
attachment of ubiquitin.  These shifts are absent in reactions lacking ATP.  C.)  Repeat 
experiment with Kv1.2C after GST cleavage showing increased electrophoretic band 
shifts that overlap in both Flag (ubiquitin) and Kv1.2 channels. 
 
Figure 4.  Kv1.2 is ubiquitylated in the rat cerebellum.  LC-MS/MS output of Kv1.2 
K437 ubiquitylation showing liquid chromatography elution peaks (top insert), 
representative MS1 detection of tryptic peptide at m/z 1064.54 (top), and second MS 
fragmentation spectrum (bottom). Table insert lists the Sequest XCorr values for the 




Figure 5. Trim32 increases Kv1.2 surface expression through ubiquitylation. Flow 
cytometry was used to monitor Kv1.2 surface expression by whole cell fluorescent 
detection after incubation with an external loop tagged Kv1.2 antibody. A.) Co-
transfection with wild type ubiquitin (WT-Ub) causes a significant decrease in surface 
Kv1.2, while co-transfection with a form of ubiquitin that cannot form chains (mUb), 
causes an increase in surface Kv1.2. B.) Like mUb, overexpression of Trim32 also 
caused increased surface Kv1.2, an effect that was attenuated by single point mutation of 
K437 (the prominent site of cerebellar ubiquitylation). C.) In cells plated to low 
confluence, Trim32 repeatedly caused a significant increase of surface Kv1.2, an effect 
that is dependent on Kv1.2 lysines shown by replacement of Kv1.2WT with Kv1.2KR. 
D.) Mutation of Trim32’s ubiquitylation catalytic RING domain, like Kv1.2KR, 
diminished the increase of surface Kv1.2 after Trim32 coexpression. E.) Using WB 
analysis, co-expression of Trim32 (middle lane compared to left lane) appears to cause 
monoubiquitylation bandshifts (~8.5kDa) of Kv1.2 similarly to monoUb (right lane 
compared to left lane). Taken together, Trim32 appears to cause an increase in surface 
Kv1.2 through a mechanism involving monoubiquitylation of the channel. * = p <0.05 ** 
= p <0.01*** = p <0.001 by students’ t-test or two-way ANOVA. Sample size (n) for 
each experiment or combined experiments are listed inside the bar graphs. 
 
Figure 6.  Trim32 lowers surface Kv1.2 independent of ubiquitylation. A.) The 
transient transfections of Figure 5C and D were repeated using HEK293 cells that were 
plated and grown to high confluence and flow cytometry assessment demonstrated that 
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under these conditions, Trim32 causes a significant decrease of surface Kv1.2 that is 
independent of both Kv1.2 lysines and Trim32 ubiquitin ligase activity. B.) Stable 
Isotope Labeling of Cells in Culture (SILAC) was used to quantitatively examine whether 
co-expression of Kv1.2 with Trim32 can alter Kv1.2’s phosphorylation state in highly 
confluent cells. In the light population, Kv1.2 was co-transfected with empty vector, 
while in the heavy population Kv1.2 was co-transfected with Trim32, and the relative 
change in the MS1 intensity spectra in the light vs. heavy fractions provided a 
quantitative measure of Trim32’s effect on Kv1.2 phosphopeptide abundance. C.) We 
find, in repeated experiments, that Trim32 strongly decreases phosphorylation of serine 
434 within Kv1.2 (C, top), but has no effect on another prevalent phosphorylation site 
serine 440 within the channel (C, bottom).  The functional role of S434 phosphorylation 
remains to be elucidated.  Using flow cytometry with T433V/S434A and S440A/S441A 
double mutants, we found the S434 but not S440 double mutant caused a dramatic 
decrease in surface Kv1.2, which facilitates Trim32’s surface Kv1.2 increasing 
mechanism (D, left and insert). Co-expression of Trim32 with S440A/S441A now caused 
surface Kv1.2 to significantly decrease. Double mutants were used to avoid MS2 
ambiguity potential phosphorylation compensation.* = p <0.05 ** = p <0.01*** = p 
<0.001 by students’t-test or two-way ANOVA. Sample size (n) for each experiment or 
combined experiments are listed inside the bar graphs. Heavy and Light SILAC peaks 
were extracted under equal LC elution peaks, and MS peaks were averaged across 





Figure 7.  Proposed model for Trim32 induced regulation of Kv1.2. The following 
model of surface Kv1.2 regulation by Trim32 is proposed: Under certain cellular 
conditions (low confluence in HEK293 cells), Trim32, through its E3 ligase RING 
domain, catalysis ubiquitylation of Kv1.2 at lysine 437 in coordination with S440/S441 
phosphorylation to promote Kv1.2 at the plasma membrane. Under different cellular 
conditions (high confluence in HEK293 cells), Trim32, independent of its RING domain, 
facilitates the removal of S434 phosphorylation to promote internalization of Kv1.2 from 
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WNKs are a family of serine/threonine kinases widely expressed in the brain 
where they are associated with several neurological disorders, including autism and 
schizophrenia. They have been most extensively studied in kidney where they regulate 
cation-chloride cotransporters. In the brain, WNK1 and its downstream target SPAK also 
regulate cation-chloride co-transporters, and are hypothesized to influence chloride 
homeostasis during inhibitory neurotransmission. Here we report that in the cerebellum 
WNK1 and SPAK complex with and regulate the voltage-gated potassium channel 
Kv1.2, indicating a new mechanism for WNK-SPAK signaling and identifying a novel 
cellular pathway for regulating neuronal excitability. Using mass spectrometry and 
immunoblot, we identified WNK1 and SPAK as components of the cerebellar Kv1.2 
protein interactome. Immunofluorescence studies revealed that WNK1 is expressed, 
along with Kv1.2, in cerebellar Purkinje cells. Kv1.2 function is regulated by its 
endocytic trafficking to and from the cell surface, and flow cytometry analysis of surface 
Kv1.2 in HEK293 cells showed that both WNK1 and SPAK influence Kv1.2 expression 
at the cell surface. In the presence of functional SPAK, WNK1 over-expression reduced 
surface Kv1.2 as did over-expression of SPAK. In contrast, WNK1 increases surface 
Kv1.2 levels when uncoupled from SPAK using either the pharmacological inhibitor 
STOCK-1S50669 or expression of a version of SPAK lacking the phosphorylation site 
required for its activation by WNK1. Evidence that the interaction between WNK1 and 
Kv1.2 is regulated in vivo comes from our finding that significantly less WNK1 co-
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immunoprecipitated with Kv1.2 of rats that had been subject to eye-blink conditioning, a 
type of cerebellar learning that we have previously shown to be influenced by Kv1.2 
regulation. We conclude that WNK1/SPAK regulation of Kv1.2 is a novel cellular 
mechanism governing cerebellar function.  
Introduction 
Mammalian with-no-lysine [K] (WNK) are a class of serine-threonine protein 
kinases that detect changes in intracellular chloride concentration [(Cl-)i]. In the kidney, 
where WNK signaling is the most studied, WNKs have been shown to both govern the 
kinase-regulation of ion transport and contribute to the development of inherited and 
acquired forms of salt-sensitive hypertension (for review, see (Hoorn & Ellison, 2012)). 
All four WNK kinase isotypes are found in the brain (Holden, Cox, & Raymond, 2004; 
Kahle et al., 2004; O'Reilly, Marshall, Speirs, & Brown, 2003; Rinehart et al., 2011; 
Verissimo & Jordan, 2001), although WNK1 and WNK2 are the most abundantly 
expressed. Despite their widespread expression in the brain, comparatively little is known 
about their function there (Delaloy et al., 2006; Rinehart et al., 2011).  
 Most studies indicate that WNKs are the chloride sensing unit of a cascade of 
kinases that ultimately control intracellular ion homeostasis. Immediately downstream of 
WNK kinases are two structurally similar kinases: oxidative stress-responsive kinase 1 
(OSR1) and STE20/SPS1-related proline/alanine-rich kinase (SPAK), both of which are 
phosphorylated and consequently activated by WNKs (Welling, Chang, Delpire, & 
Wade, 2010). SPAK and OSR1 in turn phosphorylate cation-chloride co-transporters, 
regulating their activity (Dowd & Forbush, 2003; Gagnon, England, & Delpire, 2006; 
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Piechotta, Lu, & Delpire, 2002). In the adult brain, these transporters consist mainly of 
the Na+-K+-2Cl- co-transporter NKCC1,which drive chloride influx, and the K+-Cl- co-
transporter KCC2 which drive efflux of intracellular chloride (de Los Heros et al., 2014). 
The main inhibitory neurotransmitters in the brain are gamma-amino butyric acid 
(GABA) and glycine, both of which activate ligand gated chloride channels. Thus, 
WNK/SPAK regulation of cation-chloride co-transporters has a major influence on 
excitability in the brain. Mutation or alteration of SPAK/OSR1 are correlated with 
increased neuronal activity leading to epilepsy (reviewed in (Alessi et al., 2014)), while 
defects in KCC2 are also implicated in disease state involving hyper-excitability and 
deficits in GABAA receptor mediated neuronal inhibition (Silayeva et al., 2015). 
Additionally, models of acquired epilepsy show elevated SPAK expression in 
hippocampal neurons (L. Yang et al., 2013).   
WNK and SPAK induced trafficking of cation-chloride co-transporters is well 
defined, particularly in the kidneys. Recent studies, however, have shown that SPAK is 
also able to affect trafficking other types of membrane proteins (Elvira et al., 2014; 
Elvira, Warsi, Munoz, & Lang, 2015; Fezai et al., 2014; Warsi et al., 2014). One target, 
chloride channel protein 2 (ClC-2), is a voltage -and chloride-sensitive channel that 
contributes to the regulation of neuronal excitability (Foldy, Lee, Morgan, & Soltesz, 
2010; Ratte & Prescott, 2011; Rinke, Artmann, & Stein, 2010; Warsi et al., 2014). In 
inhibitory basket cells of the hippocampus, ClC-2 was demonstrated to extrude Cl- under 
intense neural firing to maintain efficacy of GABAergic inhibition (Foldy et al., 2010). 
Other studies have proposed that under physiological conditions, ClC-2 channels permit 
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Cl- entry into the neurons to reduce neuronal excitability (Ratte & Prescott, 2011). 
Recently, overexpression of SPAK kinase was shown to modulate Kv1.5 surface levels in 
a Xenopus oocyte expression  system (Elvira et al., 2015). This finding is particularly 
interesting because it suggests roles for WNK/ SPAK that extends beyond their direct 
effects on chloride homeostasis.  
Voltage-gated potassium channels are expressed throughout the brain and have 
diverse electrophysiological effects. In the cerebellum, Kv1 family of voltage-gated 
potassium channels, in particular those harboring the Kv1.2 alpha subunit, contribute to 
excitability of Purkinje cells (PC), the main computational unit and sole output of the 
cerebellar cortex (Southan & Robertson, 1998, 2000).  In a previous study we showed 
that suppression of Kv1.2 by the neuromodulator secretin increases dendritic excitability 
of PCs. We also reported that such suppression of Kv1.2 enhanced cerebellum-dependent 
eye blink conditioning (EBC). Thus, the regulation of Kv1.2 impacts core 
neurophysiological and computational functionalities of the cerebellum, including those 
governing behavior.   (Williams et al., 2012).   In this study, we identified WNK1 and 
SPAK kinases as components of the cerebellar Kv1.2 interactome, suggesting a new 
mechanism for regulating excitability in the brain.  We report that WNK1 is present in 
cerebellar Purkinje cells along with Kv1.2.  Using a cell culture system we show that 
both kinases can regulate Kv1.2 expression at the cell surface.  Finally, we demonstrate 
that the physical association between WNK1 and Kv1.2 decreased in cerebellum from 
rats trained in an associative conditioning task, suggesting that WNK1 regulation of 
Kv1.2 contributes to higher order functions in the brain.  
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Materials and Methods 
Materials 
Antibodies: The following primary antibodies were used in this study: Flow Cytometry: A 
rabbit polyclonal antibody directed against the first extracellular loop of Kv1.2 (α-
Kv1.2e) developed in conjunction with BioSource International (Camarillo, CA)” 
(Stirling et al., 2009), Immunoprecipitation, immunofluorescence, and immunoblotting: 
mouse monoclonal Kv1.2 (K14/16; Neuromab) rabbit polyclonal C-terminal WNK1 
(GTX30695; GeneTex), rabbit polyclonal SPAK (2281S; Cell Signaling), rabbit 
polyclonal SPAK (Pierce, PA5-17338), and rabbit polyclonal GAPDH (ab9485; Abcam). 
The following secondary antibodies were used in this study: Immunofluorescence: Goat 
anti-mouse Alexa Fluor 488 (Invitrogen), Goat anti-rabbit Alexa Fluor 568 (Invitrogen), 
Goat anti-rabbit Alexa Fluor 647 (Invitrogen); Immunoblotting:  Goat anti-mouse 700 
(Invitrogen), Goat anti-mouse 800 (Rockland); Flow Cytometry: Goat anti-rabbit 
antibody conjugated to phycoerythrin/Cy5, with an excitation peak of 488 nm and an 
emission peak of 667 nm (Southern Biotech, Birmingham, AL). 
Constructs: The following DNA constructs were used in this study: Human pCMV5-
myc-WNK1 was a generous gift by Dr. Chou-Long Huang.  SPAK constructs GFP 
SPAK T233/A (DU6190) and GFP SPAKWT (DU6188) were purchased at MRC-PPU 




Treatments: STOCK1S-50699 was purchased from MolPor (MolPort-002-144-727, Riga, 
Latvia) and NaCl salt (58.44 g/mol, ≥99.0%) was purchased from Fisher Scientific 
(BP358-10). 
Cell Culture and Transfections 
Human embryonic kidney 293T cells (HEKT-cells), Human embryonic kidney 293T 
cells with WNK1 knocked out (WNK1KO cells) by CRISPR genomic editing (generated 
as described in (Roy et al., 2015)), or human embryonic kidney cells stably expressing 
Kvβ2 were used and cultured as previously reported (Nesti et al., 2004). Cells were 
plated onto 60 mm petri dishes pre-coated in polyethylenimine and allowed to grow to 
~60-80% confluence. Experimental plasmids were transfected into cells using a PEI 
transfection method: Diluted DNA (5µg) was added to PEI (1µg/µL) at a 1:1 ratio and 
immediately mixed by pipetting. Mixture was allowed to sit at room temperature for 15 
minutes before being added drop wise to cells. Transfections were checked manually 
with an arc-lamp microscope prior to proceeding (via 0.1µg EGFP DNA added to DNA 
mixture). For immunoblotting, transfected cells were lysed 48 hours later. For flow 
cytometry, 24 hours following transfection cells were re-plated to a density of 3.3 × 
104 cells/cm2 onto 35 mm petri dishes. Once cells adhered, media was aspirated, plates 
were rinsed with sterile PBS (GIBCO life sciences), and media and new serum-free 
media was given for overnight serum starvation (10-16 hours). In all experiments 
comparing multiple cells lines, each were maintained at similar passage and treated 
equally from plating to treatment. Results comparing the cell lines were analyzed blindly. 
Surface Detection of Kv1.2 and Flow Cytometry 
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Surface Kv1.2 detection: Cells were given a drug, vehicle, or no treatment before 
application of 154mM solium azide as described previously (Nesti et al., 2004). Cells 
were then lifted, put in a microcentrifuge tube, labeled for surface Kv1.2 by application 
of 0.33µg/ml α-Kv1.2e, and antibody binding detected with fluorescently conjugated 
anti-rabbit immunoglobulin G (IgG) (0.1µg/ml). Whole cell fluorescence was detected by 
a single laser flow cytometer and distribution selection and background subtraction was 
performed as previously described (Stirling et al., 2009). 
Biochemical Sample Preparation 
Immunoblot: For HEK293 cells, after lifting cells and removing a fraction for flow 
cytometry plating, the remainder of transfected cells were allowed to settle and re-grow 
to full confluence.  24-48 hours later, cells were rinsed (2 x ice-cold PBS), lifted in a lysis 
buffer (described below for tissue homogenization), incubated for 10 minutes at 55°C in 
Laemmli sample buffer containing 0.1 M dithiothreitol (DTT) (Sigma S3401-10VL), and 
resolved by SDS-PAGE and protein immunoblot as previously described (Williams et al., 
2007). 
Immunoprecipitation: Immunoprecipitation with soluble lysates from male, rat cerebellar 
tissue (5-10 week old, Sprague Dawley, Chargles River, Quebec, Canada) was performed 
with magnetic Dynabeads (Gibco, 30µl bead/ 1µg antibody) for 1 hr at 4°C. IPs were 
washed three times with lysis buffer. Lysates and IPs were analyzed by SDS-PAGE and 
Western blotting using anti-Kv1.2 (K14/16 mouse monoclonal, UC Davis), anti-WNK1 
(rabbit polyclonal C-terminal WNK1 (GTX30695; GeneTex), anti-SPAK (rabbit 
polyclonal SPAK (2281S; Cell Signaling), and anti-GAPDH (rabbit polyclonal GAPDH 
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(ab9485; Abcam).  Infrared secondary antibody signals were detected and quantified 
using an Odyssey Infrared Imager (LI-COR). For co-IP analysis by immunoblot in Figure 
1D, female rats (5 week old, Charles River, Quebec, Canada) were used.  For IPs 
processed for LC-MS/MS analysis, following SDS-PAGE electrophoresis gels were 
stained with Coomassie Brilliant Blue G-250 (cat. #20279, Lifetechnologies) to produce 
protein bands for excision. 
Immunofluorescence 
Multiphoton:  Adult rat cerebellar slices (400 µM) were fixed (4% formaldehyde cardiac 
perfusion followed by drop-in of room temperature 4% formaldehyde for 15 minutes), 
permeabilized (10% ice-cold acetone, 5 minute), blocked (10% normal goat serum in 
PBS, 1 hour), stained for Kv1.2 (1:200) and WNK1 (1:100) or SPAK (1:50) overnight, 
rinsed (5 x 5 minute rocking in NGS, given secondary antibodies with conjugated 
fluorescent probes (Alexa 488 and Alexa 586/647, 1 hour) and rinsed  again (5 x 5 
minute rocking in NGS).  Images were obtained using a Zeiss LSM 7 multiphoton 
microscope.  The Zeiss LSM-7 Dedicated Multiphoton has four non-descanned PMT 
detectors, two of which make up the highly sensitive Zeiss gallium arsenide phosphide 
BiG detector. Multiphoton excitation is generated by a Coherent Chameleon Vision II 
Titanium Sapphire pulsed IR laser, with dispersion compensation. The stage is a 
motorized Prior Z-deck, which is fully integrated into the Zeiss Zen software. A 20X Plan 
Apo 1.0 NA DIC VIS-IR water immersion lens is the main objective lens. The system 
frame is a Zeiss Axio Examiner, specifically optimized for multiphoton microscopy.  
Images were analyzed in Image J (NIH) and Zen Light 2012 software (Zeiss, Germany).  
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Co-localization was determine using the Image J Colocalization Point plugin with 
automated threshold detection that was manually verified.   
Widefield with Deconvolution:  Adult rat cerebellar slices (50 µM) were fixed (4% 
formaldehyde cardiac perfusion followed by drop-in of room temperature 4% 
formaldehyde for 15 minutes), permeabilized (0.2% Triton X-100), blocked 10% normal 
goat serum in PBS, and stained for Kv1.2 (1:200) and SPAK (1:50), and imaged using a 
DeltaVision Restoration Microscopy System (Applied Precision).  Images were acquired 
with a 100X oil immersion lens using the SoftWorks software and analyzed with NIH 
Image J.  Colocalization was determine using the Colocalization Point plugin using 
automated threshold detection that was manually verified.   
Tissue Harvest and Membrane Fractionation 
Cerebellar tissue was harvested from male (5-9 wk) Sprague Dawley rats and 
homogenized in  10 mM HEPES (pH 7.4), 0.3M sucrose, 2mM EDTA, 1mM DTT, 1mM 
NaF, 1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132 and protease 
inhibitors (HALT) using a 15mL dounce homogenizer (10-15 strokes).  Nuclear proteins 
were removed by low speed spin centrifugation (1000g for 10 min at 4°C) and samples 
were separated into membrane fractions by ultracentrifugation (200,000 for 90 min at 
4°C).  The supernatant containing cytosolic proteins was discarded and remaining non-
nuclear, membrane fraction was then re-suspended and lysed in 50mM Tris (pH 7.41), 
150 mM NaCl, 1mM EDTA, 0.25% deoxycholate, 1% NP-40, 1mM DTT, 1mM NaF, 
1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132 and protease 
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inhibitors (HALT cocktail of 100mM AEBSF*HCl, 80µM Aprotinin, 5mM Bestatin, E-
64, 1.5mM EDTA, 2mM Leupeptin, and 1mM Pepstatin A).    
In Gel Digestion and Mass Spectrometry 
Coomassie stained gel pieces were excised, diced, and subjected to in-gel digesting with 
1.25ng/µl sequence grade modified trypsin. Peptides were extracted, re-suspended, 
loaded, and separated by HPLC also as previously described (Connors et al., 2008). 
MS/MS spectra obtained by the LTQ-XL linear ion trap mass spectrometer (Thermo 
Electron) were also determined as previously described (Connors et al., 2008).  
Instrument control was performed using the Xcalibur software package (version 2.0, SR2, 
Thermo Electron). Raw data were searched against a rat sequence data base using 
Sequest software (version 27, revision 12, Thermo Electron) with trypsin enzyme 
specificity and a 2-Da mass tolerance. Cysteine residues had a static requirement of 71 
Da for acrylamide adduction. Differential modifications of 79.96 Da for serine, threonine, 
and tyrosine residues, as well as 114.0429 for lysines and 16 Da for methionine residues, 
were permitted, and phospho-specific neutral loss increases to XCorr scoring were turned 
off. 
Statistical Analysis 
Bar graphs within figures contain descriptive statistics representing the sample mean with 
error bars representing standard error of the mean (SEM).  Determination of statistical 
difference between two independent measurements was detected by one-way Student’s t 
test.  Comparison of percent changes between pairs of independent measurements was by 
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a two-way analysis of variance. Sample populations were considered to be significant at p 
< 0.05: NS = p > 0.05, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. 
Eyeblink Conditioning 
Subjects 
Male Wistar rats were obtained from Charles River (Quebec, Canada) and housed 
in pairs upon arrival with access to food and water ad libitum. Rats were single housed 
after surgery. The colony room was maintained on a 12 hour light-dark cycle (lights on at 
7:00 AM and off at 7:00 PM). Rats weighed 200-300g prior to surgery. All behavioral 
testing took place during the light phase of the cycle and all procedures were approved by 
the Institutional Animal Care and Use Committee (IACUC) at the University of Vermont. 
Surgery 
Surgeries took place 4-6 days after arrival. Surgeries were performed under 
aseptic conditions. Rats were anesthetized with 3% isoflurane in oxygen. Once the wound 
had been cleaned and the skull was dried, four skull screw holes were drilled and skull 
screws were placed as anchors for the head stage. The eyeblink portion of the surgeries 
consisted of implantation of a bipolar stimulation electrode (Plastics One, Roanoke, VA) 
that was positioned subdermally immediately dorsocaudal to the left eye. Two 
electromyogram (EMG) wires for recording activity of the orbicularis oculi muscle were 
constructed from two strands of 75-µm Teflon coated stainless steel wire soldered at one 
end to gold pins fitted into a plastic threaded pedestal connector (Plastics One). The other 
end of each wire was passed subdermally to penetrate the skin of the upper eyelid of the 
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left eye and a small amount of insulation was removed so that the bare electrodes made 
contact with the orbicularis oculi muscle. A ground wire was wrapped around two skull 
screws at one end and the other end was also soldered to a gold pin fitted into the pedestal 
connector. Once the ground wire and electrodes were placed, all were cemented to the 
skull with dental cement. The wound was numbed with a local injection of 0.15 ml 
bupivacaine, spread out over three points around the wound. The wound was salved with 
antibiotic ointment (Povidone). At the end of the surgery, rats received subcutaneous 
injections of Lactated Ringers (1ml) for hydration and ~0.3ml buprenorphine for post-
operative analgesia. A second injection of the same concentration was given ~24-hours 
after surgery. Rats were post-operatively checked daily for 4-5 days after surgery. Rats 
were given 5-6 days to recover prior to eyeblink conditioning. 
Apparatus 
Eyeblink conditioning took place in one of four identical testing chambers (30.5 x 
24.1 x 29.2 cm; Med-Associates, St. Albans, VT), each with a grid floor. The top of the 
chamber was altered so that a 25-channel tether/commutator could be mounted to it. Each 
testing chamber was kept within a separate electrically-shielded, sound attenuating 
chamber (45.7 x 91.4 x 50.8 cm; BRS-LVE, Laurel, MD). A fan in each sound-
attenuating chamber provided background noise of approximately 60 dB sound pressure 
level. A speaker was mounted in each corner of the rear wall and a light (off during 
testing) was mounted in the center of the rear wall of each chamber. The sound-
attenuating chambers were housed within a walk-in sound-proof chamber. 
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Stimulus delivery was controlled by a computer running Spike2 software (CED, 
Cambridge, UK). A 2.8 kHz, 80 dB tone, delivered through the left speaker of the sound-
attenuating chamber, served as the conditioned stimulus (CS). The CS was 295-ms in 
duration. A 15-ms, 4.0 mA uniphasic periorbital stimulation, delivered from a constant 
current stimulator (model A365D; World Precision Instruments, Sarasota, FL), served as 
the unconditioned stimulus (US) during conditioning. Recording of the eyelid EMG 
activity was controlled by a computer interfaced with a Power 1401 high-speed data 
acquisition unit and running Spike2 software (CED, Cambridge, UK). Eyelid EMG 
signals were amplified (10k) and bandpass filtered (100-1000 Hz) prior to being passed 
to the Power 1401 and from there to the computer running Spike2. Sampling rate was 2 
kHz for EMG activity. The Spike2 software was used to full-wave rectify, smooth (10ms 
time constant), and time shift (10ms, to compensate for smoothing) the amplified EMG 
signal to facilitate behavioral data analysis. 
Eyeblink Conditioning Procedure 
 At the beginning of each session, each rat was plugged in, via the connectors 
cemented to its head, to the 25-channel tether/commutator, which carried leads to and 
from peripheral equipment and allowed the rat to move freely within the testing box. 
Group Conditioned (n = 11) received 100 CS-US trials per day (intertrial interval = 20-40 
sec) for 3 days.  Group Untrained (n = 9) spent the equivalent amount of time in the 
conditioning chamber, but without any stimuli and eyelid EMG activity was sampled 




For Group Conditioned, CS-US trials were subdivided into four time periods: (1) 
a “baseline” period, 280-ms prior to CS onset; (2) a non-associative “startle” period, 0-
80ms after CS onset; (3) a “CR” period, 81-280ms after CS onset; and (4) a “UR period,” 
65-165ms after US onset. For Group Untrained, “no stimulus” trials were subdivided 
using the same time periods. In order for a response to be scored as a CR, eyeblinks had 
to exceed the mean baseline activity for that trial by 0.5 arbitrary units during the CR 
period. Eyeblinks that met this threshold during the startle period were scored as startle 
responses and were analyzed separately. The primary behavioral dependent measure for 
all experiments was the percentage of trials with an eyeblink response during the “CR 
period” across all 100 CS-US Paired trials (Conditioned group) and comparable “trial 
periods” for the Untrained group for each session.  
For the percentage of CRs, the data were analyzed using repeated measures 
ANOVAs comparing between groups across sessions. As a confirmation, a one-way 
ANOVA was run comparing the groups in the final day of acquisition. The criterion for a 
significant effect was an α-level of 0.05 or below. 
Results 
WNK1 and SPAK interact with Kv1.2 in the Brain 
Kv1.2 is expressed within the mammalian central nervous system, where, like 
other ion channels, it interacts with protein complexes that influence its function. Kv1.2 
function can be modulated by endocytic trafficking triggered by protein-protein 
interaction in cultured cells (Hattan et al., 2002; Williams et al., 2007), however the 
mechanisms governing Kv1.2 trafficking in the brain remain largely unknown. Recently, 
99 
 
we have demonstrated that Kv1.2 trafficking is modulated, at least in part, by adenylate 
cyclase/protein kinase A (AC/PKA) mediated trafficking. Regulation of Kv1.2 has 
important consequences for cerebellar function, affecting not only PC dendritic 
excitability but cerebellum-dependent associative learning as well (Williams et al., 2012).  
To expand our understanding of Kv1.2 regulation beyond known or suspected 
mechanisms, we used liquid chromatography tandem mass spectrometry (LC-MS/MS) 
analysis of Kv1.2 isolated from cerebellar tissue extracts to systematically screen and 
identify candidate proteins that may interact and modulate with Kv1.2 in the brain. Kv1.2 
was immunoprecipitated from rat cerebellum and resolved using gel electrophoresis 
(Figure1A). Protein components of the immunoprecipitate were identified using a high 
mass accuracy LTQ-Orbitrap hybrid mass spectrometer (Thermo Electron) (Figure 1B).    
The criteria for identification were 3 or more unique peptides with a Sequest cross-
correlation score (X-corr) of 2.4 or greater after first filtering all peptides to a less than 
1% false discover rate using a concatenated reverse database during Sequest searches. A 
parallel immunoprecipitation was done using mouse IgG and those non-specific 
interactions were removed from the analysis. Among the most frequently observed 
peptides are those from Kv1.2 itself, as well as proteins that we expect to interact with 
Kv1.2, such as Kv1.1 (a closely related alpha subunit that multimerizes with Kv1.2) and 
Kvβ2 (a Kv1.2 associated beta subunit), thus confirming the general methodology. We 
also identified unexpected proteins. Four of these are not readily explained (Skiv2l2, 
ZCCHC8, Acly and Pfkp). However, three others have functions suggesting they may be 
potential novel modulators of Kv1.2, including the protein kinases WNK1 and SPAK or 
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STK39 (Trim32 was investigated in a separate study). Using an LTQ Linear Quadrupole 
Ion Trap Mass Spectrometer Plus Liquid Chromatography (LCMS), which can more 
accurately detect lower-abundant protein peptides, we detected approximately 30 
additional Kv1.2-specfic interacting proteins (data not shown), with WNK1 and SPAK 
detected in five of five experiments with this instrument. Figure 1C provides peptides 
identified in one experiment, highlighting those which suggest potential WNK1/SPAK 
interaction. Immunoblot analysis corroborated the presence of WNK1 and SPAK in 
Kv1.2 immunoprecipitated from the cerebella of both male and female adult rats (Figure 
1D).      
WNK1 Localizes with Kv1.2 in Purkinje Cells 
WNK1 and SPAK are known to physically interact with each other and to 
regulate ion transporter function in the brain (McCormick & Ellison, 2011; B. E. Xu, 
Lee, et al., 2005), however their potential regulation of ion channels in the brain has been 
unexplored. As a first step in determining whether WNK1 and SPAK are involved in 
cerebellar Kv1.2 function we sought to characterize their relative anatomical localization. 
Kv1.2 protein is expressed in two anatomical regions of the cerebellar cortex: the axon 
terminals of basket cells (BC) where they influence inhibitory synaptic input to PCs, and 
in the dendrites of PCs where they influence excitatory synaptic input (Khavandgar et al., 
2005; Koch et al., 1997). Previous in situ hybridization studies have identified WNK2 
mRNA in cerebellar granule cells and PCs as well as neocortical pyramidal cells and 
thalamic relay cells (Rinehart et al., 2011). A WNK1 reporting transgenic mouse found 
WNK1 expression in cerebellar granule and PCs (Delaloy et al., 2006). Using 
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immunofluorescence (IF) in cerebellar slices we confirmed WNK1 is highly expressed in 
the cerebellum, with strong signal in PCs as well as some detection in granule cells and 
molecular layer interneurons (Figure 2A). WNK1 signal was prominent in PCs soma 
(Figure 2A, circle) as well as in PC dendrites within the molecular layer (Figure 2A, 
arrows). Little WNK1 signal was detected in BC axon terminal (Figure 2A, box), a site 
with dense Kv1.2 expression, suggesting that the WNK1 detected by LC-MS/MS was 
associated with Kv1.2 originating in PCs but not BCs. Multiple attempts were made to 
image SPAK as well, however the commercially available antibodies used gave poor 
signal above background. Thus, the relative localization of SPAK and Kv1.2 in the 
cerebellum was not determined (images depicting potential SPAK localization are 
provided in Appendix B, Figure B:2).  
WNK1 Influences Expression of Kv1.2 in Cells Stably Expressing Kvβ2  
 To determine if WNK signaling influences expression of Kv1.2, we first 
performed a series of transient transfection experiments in cultured cells stably 
expressing Kvβ2, an auxiliary Kv channel subunit important for Kv1.2 biosynthetic 
trafficking (Manganas & Trimmer, 2000; Rhodes et al., 1996). First, we asked whether 
WNK1 alters the surface expression of Kv1.2 measured using flow cytometry as 
previously described (Nesti et al., 2004; Stirling et al., 2009). Images depict normalized 
count which we interpret as an objective measure of surface Kv1.2. Kv1.2 surface 
expression was significantly lower in cells expressing WNK1 relative to those expressing 
Kv1.2 alone (-41%, t(df) = 12.45(46), p < 0.0001, n = 24 each) (Figure 3, top).WNK 
kinases have been shown to decrease surface expression of ion channels through 
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trafficking, such as the WNK1-induced clathrin-mediated endocytosis of renal outer 
medullary potassium channel (ROMK) channels (He et al., 2007; C. L. Huang et al., 
2008); however, WNK kinases can also decrease the total expression of ion channels, 
such as the WNK4 driven increase of lysosomal degradation of renal large-conductance 
Ca(2+)-activated K(+) (BK) channels (Z. Wang et al., 2013; Yue et al., 2013). We 
therefore next asked if co-expression of WNK1 alters total Kv1.2 protein levels in these 
cells. Interestingly, while co-expression of WNK1 significantly decreased channel 
surface expression, total expression of Kv1.2 significantly increased (+110%, t(df) = 
12.79(4), p < 0.0005, n = 5 (+ vector), 6 (+ WNK1) (Figure 3, middle and bottom). 
Knockout of WNK1 Alters WNK1-induced Modulation of Kv1.2 Expression 
HEK293 cells contain endogenous WNKs, including WNK1, which could 
confound interpretation of experiments involving WNK1 over-expression. To address 
this we used HEK293 cells in which endogenous WNK1 expression had been disrupted 
(WNK1KO cells) using Clustered Regularly Interspaced Short palindromic Repeats 
(CRISPRs)/Cas-mediated genome editing (developed and characterized in (Roy et al., 
2015)). These cells harbor the large-T antigen and are derived from a parent line of 
HEK293T cells (Roy et al., 2015). Over-expression of WNK1 in the parent HEKT-cell 
line produced a small but still significant decrease in surface Kv1.2 relative to cells 
transfected with empty vector lacking the WNK1 gene (Figure 4, top left)  (-9.2%, t(df) 
=  4.61(22), p < 0.0001, n = 12 each). We next tested the effect of WNK1 on Kv1.2 in 
WNK1KO cells. Interestingly, baseline surface Kv1.2 was significantly lower in the 
WNK1KO relative to their parent HEKT cell line (-21.8%, t(df) = 12.60(22), p < 0.0001, 
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n = 12 each). From that reduced Kv1.2 baseline, expression of WNK1 in the WNK1KO 
cells caused surface Kv1.2 to increase significantly (+13.1%, t(df) =  2.84(21), p < 0.01 n 
= 12 each). Immunoblotting detected increased total channel protein following co-
expression of WNK1, however the increase was only significant in the HEKT-cells 
(+33%, t(df) = 4.08(8), p < 0.005, n = 5 each) but not the WNK1KO cells (+28%, t(df) = 
1.75(8), p = 0.119, n = 5 each). Together, these results show that co-expression of WNK1 
alters Kv1.2 at the cell surface, and that the presence of endogenous WNK1 affects both 
the baseline amount of Kv1.2 at the cell surface and the manner with which 
overexpressed WNK1 influences the channel at the surface. WNK1 was not detected to 
decrease total channel protein under the conditions tested. These results suggest that 
WNK1 effects on Kv1.2 might be non-linear, with lower WNK1 levels (as in WNK1 
expressed in WNK1KO cells) increasing Kv1.2 surface expression and higher levels 
decreasing it.  
Activation of Downstream SPAK/OSR1 Influences WNK1-induced Modulation of 
Kv1.2 
We next asked if the downstream kinases SPAK/OSR1 are involved in WNK1 
induced alteration of surface Kv1.2. In order for SPAK/OSR1 to become phosphorylated 
and subsequently activated by WNK kinases, SPAK/OSR1 must first interact with WNK 
via a conserved carboxy-terminal (CCT) domain which binds to an RF(X)V/I domain 
within WNK kinase (Villa et al., 2007). A small-molecule pharmacological compound, 
STOCK1S-50699, disrupts this interaction, preventing WNK from activating 
SPAK/OSR1, thus inhibiting WNK-dependent activity of SPAK/OSR1 on downstream 
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targets (de Los Heros et al., 2014; Mori et al., 2013). We therefore used STOCK1S-
50699 to investigate whether WNK1 alters surface expression of Kv1.2 independently of 
OSR1/SPAK (Figure 5A). To our surprise, treatment with STOCK1S-50699 (30 
minutes, 20µM) decreased surface Kv1.2 levels in either HEKT-cells (-70%, t(df) = 
15.55(15), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001) or WNK1KO cells (-68%, 
t(df) = 13.58(16), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001). From this reduced 
baseline, co-transfection with WNK1 in HEKT-cells no longer decreases surface Kv1.2 
(+13.2%, t(df) = 1.47(9), p = 0.1762, n = 6 each), suggesting that the mechanism by 
which WNK1 decreases surface Kv1.2 may be dependent on activation of SPAK/OSR1 
by WNK kinases. Additionally, co-transfection of Kv1.2 with WNK1 in WNK1KO cells 
treated with STOCK1S-50699 resulted in a significant increase of surface Kv1.2 (+50%, 
t(df) = 4.95(10), p < 0.001, n = 6 each). Thus, expression of WNK1 in a WNK1 knockout 
background drives an increase in surface Kv1.2, an effect greatly enhanced by blocking 
SPAK/OSR1 activation. This finding suggests that WNK1 might affect Kv1.2 trafficking 
in SPAK-dependent and SPAK-independent ways. 
SPAK Influences Surface Kv1.2 Regardless of WNK1 
 Given that WNK1 is capable of modulating Kv1.2 via a SPAK-independent 
mechanism, we asked whether SPAK can affect Kv1.2 independently of WNK1. Both 
HEKT-cells and WNK1KO cells were transfected with either Kv1.2 alone (+ empty 
vector) or co-transfected with SPAKWT (Figure 5B). Like WNK1, co-expression of 
SPAK in HEKT-cells caused a significant decrease in surface Kv1.2 (-26%, t(df) = 
4.53(16), p < 0.0005, n = 6 (+ vector), 12 (+SPAKWT). As also observed in Figure 5A, 
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switching from HEKT-cells to WNK1KO cells significantly decreased baseline surface 
Kv1.2 levels (-39%, t(df) =  (4.89(10), p < 0.001, n = 6 each).  However, co-expression 
with SPAK in WNK1KO cells caused a further significant decrease in surface Kv1.2 (-
18%, t(df) =  2.31(16), p < 0.05, n = 6 (+ vector), 12 (+SPAKWT). Interestingly, SPAK 
over-expression had no significant effect on total Kv1.2 protein levels (+13%, t(df) = 
1.42(10) p = 0.189, n = 6 each), but significantly increased total Kv1.2 in WNK1KO cells 
(+113%, 11.41(10), p < 0.0001, n = 6 each) (Figure 5C). This increase in total Kv1.2 is 
similar to that caused by over-expression of WNK1 in the Kvβ2 stable HEK cell line 
(Figure 3), suggesting the effect involved WNK1 activation of endogenous SPAK. To 
address the possibility that over-expression of SPAK in WNK1KO cells might involve 
other endogenous WNKs, we substituted SPAKWT with SPAKT233A, a version of 
SPAK that cannot be phosphorylated and thus activated by WNKs (Vitari, Deak, 
Morrice, & Alessi, 2005).  In HEKT-cells, overexpression of SPAKT233A caused a 
dramatic decrease in surface Kv1.2 (-38%, p < 0.0001, n = 6 (+ vector), 12 
(+SPAKT233A), again implying that SPAK can decrease surface Kv1.2 independently of 
WNK activation. Interestingly however, in WNK1KO cells, SPAKT233A resulted in a 
moderate, non-significant decrease of surface Kv1.2 (-10%, t(df) = 1.38(14), p = 0.189, n 
= 6 (+ vector), 10 (+ SPAKT233A). Therefore, although SPAK is able to regulate surface 
Kv1.2 without being activated by WNKs, its effects on Kv1.2 trafficking is still 
influenced by WNK1.   
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Cerebellum-dependent Learning Decreases WNK1 Interaction with Kv1.2 
Neurological WNK1 is highly localized to the cerebellum (Delaloy et al., 2006; 
Rinehart et al., 2011), but its effect on overall cerebellar function is not known. Since we 
demonstrated that WNK1 associates with Kv1.2 in the cerebellum (Figure 1), we 
wondered if we could utilize cerebellar-dependent learning, a process we have shown 
previously to involve Kv1.2, to demonstrate a functional role for WNK1 in the 
cerebellum. In a previous study, blocking Kv1.2 via infusion of a specific Kv1.2 blocker, 
tityustoxin-Kα, into the lobulus simplex of the cerebellum enhanced delay eyeblink 
conditioning (Williams et al., 2012). Delay eyeblink conditioning (EBC) is a classical 
conditioning paradigm that engages a discrete brainstem-cerebellar neural circuitry 
(Thompson & Steinmetz, 2009). Furthermore, the neuropeptide secretin was previously 
associated with Kv1.2 trafficking (Williams et al., 2012). Intracerebellar infusions of 
secretin or a secretin receptor antagonist, facilitated and impaired acquisition of EBC, 
respectively (Fuchs et al., 2014, Williams et al., 2012). Since suppression of Kv1.2 
enhances EBC learning, we hypothesized that EBC itself might affect Kv1.2 regulation, 
potentially by influencing the composition of its protein interactome. To test this, male 
Wistar rats underwent either no training (Untrained) or a short delay EBC paradigm 
(Conditioned) and LC-MS/MS analysis was used to identify Kv1.2 interacting proteins. 
Immediately following the last trial of EBC training, rats were sacrificed and the lobulus 
simplex region (HVI) of the cerebellum, ipsilateral to the trained eye, was harvested and 
flash frozen in liquid nitrogen (Figure 6A). Rats in group Conditioned learned to make a 
conditioned response significantly more than rats that those of group Untrained (Figure 
6B). The tissue was pooled within experimental condition and subject to Kv1.2 
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immunoprecipitation followed by analysis by LC-MS/MS (Figure 6C). Peptides of 
Kv1.2 detected for each group were roughly equal (Conditioned: 55 peptide, Protein 
XCorr = 3.76); Untrained 43 peptide, Protein XCorr = 3.66)). In both groups, WNK1 and 
SPAK were detected as interacting proteins, however nearly half as many WNK1 
peptides were detected in the Conditioned group (Conditioned: 10 total, 7 unique, Protein 
XCorr = 3.03 vs. Untrained: 19 total, Protein XCorr = 3.02), with roughly equal SPAK 
peptides between groups (Paired: 13 total, protein XCorr = 3.25; Unpaired: 9 total, 
Protein XCorr = 3.10). The level of Kvβ2, which binds Kv1.2 readily, was unchanged 
between groups (Conditioned: 39 total, Protein XCorr = 3.16; Untrained: 31 total, Protein 
XCorr = 3.26). Immunoblot analysis and of Kv1.2 and co-immunoprecipitated WNK1 
confirmed a learning-induced drop in WNK1 association with Kv1.2 caused by learning, 
with the Untrained group showing a 3.6 fold increase in Kv1.2 associated WNK1 (Figure 
6D).   
Discussion 
The WNK/SPAK signaling pathway has long been known to regulate cation-
chloride cotransporters in the kidney and more recently have been shown to do so in the 
brain. Cation-chloride co-transporters have a major impact on intracellular chloride 
concentration, and thus on the driving force for chloride currents through GABAA and 
glycine receptors. The recent finding that WNK1 is a chloride sensor has led to the 
hypothesis that WNK/SPAK phosphorylation and regulation of cation-chloride co-
transporters has a key role in maintaining intracellular chloride levels during 
neurotransmission involving ligand-gated chloride channels. The findings presented here 
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expand this paradigm by identifying the voltage-gated potassium channel Kv1.2 as a new 
target for WNK and SPAK in the brain.  
            Using mass spectrometry, we identified WNK1 and SPAK as components of the 
cerebellar Kv1.2 interactome (Figure 1). We then used HEK239 cells as a model system 
to assess the role of WNK1 and SPAK on Kv1.2 function (Figures 3-5). Since Kv1.2 
electrophysiological function is regulated by endocytic trafficking (Nesti et al., 2004), we 
assessed the effects of WNK1 and SPAK on Kv1.2 levels at the cell surface. Over-
expression of either WNK1 or SPAK decreased Kv1.2 surface levels in wild-type 
HEK293 cells (Figures 3-5). However, in HEK cells in which endogenous WNK1 
expression had been ablated using CRISPR genomic editing (Roy et al., 2015), over-
expression of WNK1 increased surface Kv1.2 levels (Figures 4-5). We attribute the 
WNK1 induced drop in Kv1.2 surface levels in wild-type HEK192 cells to its activation 
of SPAK since the dramatic internalization of Kv1.2 by SPAK over-expression was not 
eliminated in WNK1 knockout cells (Figure 5). In contrast, disruption of WNK-SPAK 
interaction by over-expressing a version of SPAK lacking the WNK phosphorylation site 
(SPAK-T233A) or with the small-molecule inhibitor Stock1S-50699, reversed the 
polarity of the effect of WNK1 on Kv1.2 surface levels (Figure 5). Collectively, these 
findings suggest that WNK1 can affect Kv1.2 trafficking not only by activating SPAK, 
but also by a SPAK-independent mechanism as well.  
Given that WNK1 is a chloride sensor, it is possible that WNK/SPAK signaling 
might link Kv1.2 function to GABAA or glycine receptor activity in the brain. Purkinje 
cell dendrites, which harbor both Kv1.2 and WNK1 (Figure 2), receive abundant input 
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from GABAergic interneurons. The primary effect of this synaptic input is inhibitory via 
GABAA receptor mediated chloride influx. The resulting increase in intracellular chloride 
levels would be expected to inhibit WNK1 and, as hypothesized for other cell types, 
relieve WNK1 mediated inhibition of KCC1. This, in consequence, would increase 
chloride extrusion by KCC1, thus providing a feedback mechanism for maintaining 
intracellular chloride homeostasis. However, our data suggests a parallel mechanism 
whereby chloride mediated inhibition of WNK/SPAK activity would also decrease 
endocytosis of Kv1.2. This would in turn increase Kv1.2 levels at the cell surface, 
facilitating its ability decrease dendritic excitability. This hypothetical mechanism would 
suggest a novel role for WNK1 as a mechanism for linking inhibitory transmission with 
Kv1.2 via a mechanism that does not directly involve voltage sensitivity. Such a 
mechanism could serve to extend the inhibitory effect of GABAergic transmission on 
membrane excitability beyond the period of direct GABAA receptor activation.      
Intriguing evidence that WNK1 is involved in Kv1.2 regulation in vivo comes 
from our finding that the physical interaction between WNK1 and Kv1.2, or at least the 
stability of the interaction during immunoprecipitation, is significantly altered by 
experience in live, behaving animals.  Pairing of CS and US in an EBC paradigm roughly 
halved the amount of WNK1 that co-immunoprecipitated with Kv1.2 (Figure 6). 
Interestingly, the channel’s interaction with SPAK was not decreased. Why this is the 
case remains to be determined, although it might indicate that WNK1 and SPAK interact 
with Kv1.2 via different mechanisms, potentially via different sites within the 
channel. We also note that phosphorylation at two sites within Kv1.2, S434 and S468 was 
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detected in the CS-US paired but not unpaired condition. Whether this is related to EBC 
induced changes in WNK1 interaction with Kv1.2 remains to be determined. The 
functional effect of decreased WNK1 interaction with Kv1.2 can also only be speculated 
on at this point. In previous studies we have shown that suppressing Kv1.2 activity 
enhances EBC (Fuchs et al., 2014; Williams et al., 2012). It is possible that, as in HEK 
cells (Figures 3-5), cerebellar WNK1 might act independently of SPAK to enhance 
surface Kv1.2 levels. Reducing WNK1 interaction with Kv1.2 would thus reduce surface 
Kv1.2 levels, possibly enhancing EBC.  
Throughout our experiments, we did not deduce whether WNK1 or SPAK 
directly bind Kv1.2, leaving the possibility that other intermediary proteins may 
contribute to WNK signaling induced trafficking of Kv1.2. Additionally, the current 
studies do not directly address the mechanism by which WNK1 or SPAK affect surface 
Kv1.2 levels. Our findings that the WNK-induced decreases in surface Kv1.2 levels in 
HEK293 cells was accompanied by an apparent increase in total Kv1.2 protein suggest 
that WNK modulates endocytic trafficking, either by enhancing endocytosis or 
decreasing recycling of endocytosed channel back to the plasma membrane. It is likely 
that WNK1 or SPAK affect Kv1.2 phosphorylation and future in vitro kinase assays or 
quantitative LC-MS/MS approaches such as Stable Isotope Labeling in Culture (SILAC) 
could help determine this.  Finally, intracranial infusion of Stock-1S-50699 into the 
lobulus simplex of adult rats prior to EBC training would provide a powerful future 
experiment to observe whether disruption of WNK:SPAK binding alters the progression 
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Figure Legends 
Figure 1.  Kv1.2 associates with WNK1 and SPAK kinases in the cerebellum.   A: 
Representative protein gel scan following immunoprecipitation of Kv1.2 or mouse IgG 
from cerebellar tissue.  Arrows indicate molecular weight range for Kv1 channels (~80-
100kDa), WNK kinases (> 250kda), and SPAK (~65Kda).   B:  A full interactome of 
Kv1.2 in the cerebellum as detected by LTQ Linear Quadrupole Ion Trap-Orbitrap Mass 
Spectrometer Plus Liquid Chromatography (Thermo-Fisher Scientific) following Kv1.2 
IP (non-specific proteins detected in IgG IP removed).  Peptides detected relative to 
WNK:SPAK interaction are highlighted for observation. C:  Tryptic peptides from 
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WNK1 and SPAK detected by LTQ Linear Quadrupole Ion Trap Mass Spectrometer Plus 
Liquid Chromatography (Thermo-Fisher Scientific) following IP of Kv1.2 in the 
cerebellum.  No peptides of WNK1 or SPAK were detected from IgG controls. WNK 
peptides containing SPAK binding RF(x)V/I domain and SPAK T-loop phosphorylation 
are highlighted.   Non-Orbitrap interactome of Kv1.2 was performed in 3 total repeats.  
D:  Immunoblots demonstrating co-IP of both WNK1 (left, 7.5% gel) and SPAK (right, 
10% gel) with Kv1.2 from female, cerebellar tissue.   
Figure 2. WNK1 localizes to PC cell bodies and dendrites. A: Multiphoton imaging 
demonstrating that WNK1 (red) strongly localizes to PC cell bodies and processes of the 
molecular layer where Kv1.2 is also present (green). Insert and merge show that the 
overlap within the dendritic processes is not exact, with WNK1 giving a punctate 
appearance alongside the processes. Insert scale bar represents 10µm. B: Secondary only 
controls showing no non-specific fluorescence within the microscopy. Multiphoton 
images were obtained on a Zeiss LSM 7 multiphoton microscope with a 20X water 
immersion lense and analyzed in Image J (NIH) and Zen Light 2012 software. Widefield 
images were acquired using a 100X oil immersion lenses using the SoftWorks software 
and analyzed with NIH Image J. Colocalization was determine using the Colocalization 
Point plugin using automated threshold detection that was manually verified. Neither 





Figure 3. WNK1 alters both total and surface Kv1.2 expression in HEK293 cells 
stably expressing Kvβ2. Top: WNK1 co-expressed with Kv1.2 caused a significant 
decrease in surface Kv1.2 expression in HEK293 cell lines stably expressing beta subunit 
Kvβ2 (-41%, t(df) = 12.45(46), p < 0.0001, n = 24 each).  Middle, bottom:  WNK1 co-
expressed with Kv1.2 caused a significant increase in total Kv1.2 expression in HEK293 
cell lines stably expressing Kvβ2 (+110%, t(df) = 12.79(4), p < 0.0005, n = 5 (+ vector), 6 
(+ WNK1).  
 
Figure 4. Knockout of WNK1 alters the response of overexpressed WNK1 in 
HEK293T cells.  Top: In control HEK293T cells (HEKT-cells), WNK1 also but more 
modestly significantly decreased surface Kv1.2 (-9.2%, t(df) =  4.61(22), p < 0.0001, n = 
12 each).  In HEK293T cells deficient of endogenous WNK1 (WNK1KO cells), 
overexpression of WNK1 caused surface Kv1.2 to significantly increase +13.1%, t(df) =  
2.84(21), p < 0.01 n = 12 each. Switching from HEKT-cells to WNK1KO cells also 
casued baseline surface Kv1.2 to drop (-21.8%, t(df) = 12.60(22), p < 0.0001, n = 12 
each). Middle, bottom:  Co-expression of WNK1 caused a significant increase in HEKT-
cells (+33%, t(df) = 4.08(8), p < 0.005, n = 5 each) and a similar although non-significant 
increase in WNK1KO cells compared to Kv1.2 + vector only ((+28%, t(df) = 1.75(8), p = 
0.119, n = 5 each). 
 
Figure 5. SPAK influences Kv1.2 expression in HEK293 cells.  
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A: After treating either HEKT-cells or WNK1KO cells with the WNK/SPAK binding 
inhibitor stock-1S50699, Kv1.2 baseline surface expression (Kv1.2 + empty vector) 
dramatically dropped compared to vehicle treated cells in both HEKT-cells (-70%, t(df) =  
15.55(15), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001) or WNK1KO cells (-68%, 
t(df) = 13.58(16), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001). From this baseline, 
WNK1 overexpression in HEKT-cells caused a non-significant increase of surface Kv1.2 
(+13.2%, t(df) = 1.47(9), p = 0.1762, n = 6 each) and a dramatic, significant increase in 
WNK1KO cells (+50%, t(df) =  4.95(10), p < 0.001, n = 6 each).  B: Top: Co-expression 
of Kv1.2 with SPAKWT caused a significant decrease in surface Kv1.2 in both HEKT-
cells (-26%, t(df) =  4.53(16), p < 0.0005, n = 6 (+ vector), 12 (+SPAKWT) and 
WNK1KO cells (-18%, t(df) =  2.31(16), p < 0.05, n = 6 (+ vector), 12 (+SPAKWT), and 
switching from HEKT-cells to WNK1KO cells significantly dropped baseline surface 
Kv1.2 (-39%, t(df) =  (4.89(10), p < 0.001, n = 6 each).  In T-cells, replacing SPAKWT 
with WNK1 insensitive SPAKT233A still caused a significant decrease of surface 
channel (-38%, p < 0.0001, n = 6 (+ vector), 12 (+SPAKT233A) and in WNK1KO cells, 
replacing SPAKWT with SPAKT233A caused a non-significant decrease in surface 
Kv1.2 (-10%, t(df) =  1.38(14), p = 0.189, n = 6 (+ vector), 10 (+ SPAKT233A). Middle, 
bottom:  Co-expression with SPAK did not significantly increase total channel protein in 
HEKT-cells (+13%, t(df) = 1.42(10) p = 0.189, n = 6 each) but did in WNK1KO cells 




Figure 6. WNK1 association with Kv1.2 is decreased in the lobules simplex following 
EBC learning. A: Wistar were given either a paired conditioning or non-stimulated 3 
session training session to develop EBC prior to LC-MS/MS analysis. Approximate 
region of the cerebellum containing the lobules simplex was dissected and pooled 
together for each training group while the remainder was discarded (2 paired subjects 
were removed for equal sample sizes). Protein gel scan of Kv1.2 IPs from trained or 
untrained lobules simplex dissections demonstrates density of proteins similar to whole 
cerebellar homogenates (Figure 1). C: Demonstration of successful acquisition training 
for the conditioned group.  B: LC-MS/MS output shows decreased WNK1 peptide 
detection following acquisition compared to untrained. SPAK (STK39) peptides were 
lightly increased within a reasonable range of error.  Two phosphorylation states of 
Kv1.2 (S434 an S468) were detected only in the Conditioned group while S440/441 was 
detected equally. D: Immunoblot of the same IPs detected a 3.6 fold decrease of WNK1 














Figure 3:3 WNK1 alters both total and surface Kv1.2 expression in HEK293 cells 














Figure 3:6 WNK1 association with Kv1.2 is decreased in the lobules simplex 
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CHAPTER 4: COMPREHENSIVE DISCUSSION 
Overview  
In the preceding chapters, a proteomic assessment of Kv1.2 purified from native 
tissue extracts enabled the discovery of novel protein associations with Kv1.2 in the 
cerebellum. A sample of these associations was selected for two studies in which the 
interactions were further validated and tested in cultured cells which ultimately yielded 
working models for Kv1.2 modulation in the brain. These models also further utilized the 
power of mass spectrometry by incorporating post-translational modifications of both 
Kv1.2 and interacting protein partners that were also identified by mass spectrometry 
from cerebellar tissue. 
 In Chapter 2, the hypothesis that the ubiquitin ligase Trim32 modulates surface 
Kv1.2 through channel ubiquitylation was tested. Using mutagenesis, quantitative 
proteomics, and biochemistry, a model was developed in which Trim32, through the 
coordinated interplay of channel phosphorylation and ubiquitylation, modulates 
expression of Kv1.2 at the plasma membrane. 
 In Chapter 3, the hypothesis that the chloride-sensitive WNK signaling pathway 
regulates Kv1.2 was tested. Using a knockout cell line, pharmacology, and mutagenesis, 
it was determined that both WNK1 and its downstream target SPAK impact Kv1.2 
expression at the plasma membrane, and a working model was developed in which 
WNK1 and SPAK modulate Kv1.2 through complementary mechanisms. In the 
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conclusion of this study, mass spectrometry and biochemistry demonstrated that the 
association of WNK1 with Kv1.2 changed following cerebellum-dependent learning. 
Given that suppression of Kv1.2 can alter cerebellar-dependent learning (Williams et al. 
2012), this provided framework for future studies to investigate a potential impact of this 
association on behavior. 
 Collectively, this work demonstrates the first evidence to support roles for Trim32 
and WNK1 on the expression and trafficking of voltage-gated potassium channels. 
However, both studies raise several questions.  
Excitability Control as a Role for Trim32 in the Adult Brain 
Contribution of Trim32 to Neuronal Excitability 
The preceding work in Chapter 2 demonstrated evidence for an interaction 
between Kv1.2 and Trim32 and proposed a complex model of modulation of Kv1.2 by 
Trim32 in the brain. We did not, however, investigate the influence of Trim32 on 
membrane potential. There are currently no reported pharmacological agents that 
manipulate Trim32 activity or expression, complicating our ability to investigate Trim32 
in vivo. Although Trimk32KO mice are not commercially available and we were unable 
to obtain a donation from other labs possessing Trim32KO colonies, companies such as 
Applied Biological Materials (ABM) and Santa Cruz have recently made viral constructs 
that utilize CRISPR technology to genetically remove Trim32 in vivo. Comparing the 
electrophysiology of neurons of a Trim32KO rodent to that of a normal one would 
provide a relatively straight forward approach to address this question. Alternatively, and 
perhaps more simplistically, culture systems such as HEK cells which lack endogenous 
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Trim32 could be utilized to compare membrane potential from cells transiently 
transfected with a Trim32 construct to those that were not. 
Aside from the work presented in Chapter 2, the most compelling evidence in the 
literature that links Trim32 to neuronal excitability is the recent connection of Trim32 
and Autism co-morbid with epilepsy.  
Epilepsy Co-morbid with Autism 
According to the Center for Disease Control (CDC), one in 68 children in the 
United States have a form of Autism Spectrum Disorder (ASD), a spectrum of complex 
neurological diseases characteristic of difficulties in social interaction, verbal and 
nonverbal communication, and repetitive disorder. Among ASD patients, a seizure 
occurrence rate of up to 40% of ASD has been reported (Tuchman & Rapin, 2002). 
Anywhere from 7-46% of ASD patients are also affected with epilepsy (Bolton et al., 
2011; Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005; Giovanardi Rossi, Posar, 
& Parmeggiani, 2000), a seizure disorder which involves disturbances in electrical 
activity in the brain caused by brain injury, genetics, or as is often the case, for unknown 
reasons. 
Epilepsy is one of the most common neurological diseases occurring in children, 
with incidence ranging from 41-187/100,000 dependent of demographic factors 
(reviewed recently in: (Camfield & Camfield, 2015)). Like ASD patients, who may 
display symptoms of epilepsy, 15-35% of children with epilepsy may show symptoms of 
ASD (Matsuo, Maeda, Sasaki, Ishii, & Hamasaki, 2010; Saemundsen, Ludvigsson, 
Hilmarsdottir, & Rafnsson, 2007; Steffenburg, Steffenburg, & Gillberg, 2003). Despite 
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the frequent co-morbidity of these neurological diseases, the mechanisms behind the co-
occurrence of epilepsy and ASD phenotypes are unclear and complex. Various 
neurobiological mechanism critical to early brain development seem to be altered, and 
key neuronal processes such as synaptic plasticity, GABA transmission, and functional 
connectivity are impacted (Stafstrom, Hagerman, & Pessah, 2012; Tuchman, Moshe, & 
Rapin, 2009). 
Epilepsy Co-morbid with Autism May Link Trim32 with Membrane Excitability 
Mutations of the Trim32 gene have been identified as a risk factor for ASD, and a 
recent study on genetic screening of ASD patients identified Trim32 as one of 12 
candidate genes associated with comorbidity of ASD and epilepsy in children. The 
majority of genes identified are involved with formation, maintenance, or remodeling of 
the synapse, for the first time placing Trim32 in a category of genes that influence 
neuronal and synaptic activity (Lionel et al., 2011; Lionel et al., 2014; Lo-Castro & 
Curatolo, 2014).  
Trim32 is a small gene nested within an intron of ASTN2 located along 
chromosome locus 9q33.1. A recent study utilized clinical microarray data to 
systematically screen for novel mutations at this loci and found that exonic deletion or 
duplication of ASTN2 was significantly enhanced in male patients with 
neurodevelopmental disorders (NDD), and 27 of 46 deletions (no duplications) also 
affected Trim32. Twelve of the subjects referred for the genetic study were ASD patients. 
The authors also utilized comprehensive gene expression data from the BrainSpan 
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database and found that, in concordance with Trim32KO mice, Trim32 is most highly 
expressed in the cerebellar cortex (Lionel et al., 2014).  
As pointed out by De Smet et al., neuroanatomical, neuroimaging, and clinical 
studies combined have extended the role of the cerebellum beyond motor control to the 
modulation of cognitive and affective processing (De Smet, Paquier, Verhoeven, & 
Marien, 2013). Damage to the cerebellum by injury, birth defect, and even tumor growth 
can lead to neurological disruptions such as emotional outbursts, mood changes, 
difficulty understanding social cues, and repetitive behaviors, all of which are 
symptomatic of ASD. Additionally, reduced PC volume in the cerebellum is a consistent 
finding of post-mortem ASD patients and rodent models (Kern, 2003; Piochon et al., 
2014; Whitney et al., 2008), and mice lacking the Autism-linked genes TSC1/2 displayed 
both decreased PC expression and Autistic-like behavior (Reith et al., 2013; Tsai et al., 
2012).  
 Altogether, epilepsy within ASD may link a role for Trim32 in neuronal 
excitability, and the cerebellum provides an appropriate route for investigating this role 
given the high expression of Trim32 and emerging roles of ASD pathology. Additionally, 
Kv1 channels, which are also highly expressed in the cerebellum, are strongly involved in 
seizures, a marked phenotype of epilepsy involving altered neuronal excitability. 
The Role of Kv1.2 in Epilepsy and Seizure 
Mutation or deletion of the genes encoding Kv1.1 and Kv1.2 result in 
neurological disorders with disrupted excitability in both humans and rodents (Adelman, 
Bond, Pessia, & Maylie, 1995; Brew et al., 2007; Buffington & Rasband, 2011; 
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Kullmann & Hanna, 2002; Leao, Berntson, Forsythe, & Walmsley, 2004; Smart et al., 
1998; Wimmer, Reid, So, Berkovic, & Petrou, 2010). Both Kv1.1 and Kv1.2 null mice 
have spontaneous seizures, however the seizure disorder models are different (Robbins & 
Tempel, 2012). Deletion of Kv1.1 can cause epilepsy in mice with spontaneous seizures 
throughout life (Smart et al., 1998), and only half of the Kv1.2 null mice survive to 
adulthood (Wenzel et al., 2007). Kv1.2 null mice present a more severe seizure and are 
lethal beyond post-natal day 19 (Brew et al., 2007) with seizures characteristic of those in 
the brainstem (Browning, 1986; Gale, 1992). Seizure activity produces a reduction of 
Kv1.2, but not Kv1.1,  mRNA in dentate granule cells of the hippocampus, and treatment 
with anticonvulsive drugs both protect animals from seizure and prevent reduction of 
Kv1.2 (Tsaur, Sheng, Lowenstein, Jan, & Jan, 1992). If epilepsy connects Trim32 to 
neuronal excitability, then Kv1 channels such as Kv1.2 are clear candidates for 
involvement in this mechanism.  
Conclusion 
The work of Chapter 2 provided evidence that the ubiquitin ligase Trim32 
associates with Kv1.2 in the brain and modulates the channels’ function. Given the 
literature linking Trim32 with epilepsy in ASD patients, and the pivotal role Kv1 
channels can play in epileptic seizure, further experiments may identify Trim32 as a 
modulator of neuronal excitability and thus provide a novel physiological role for Trim32 
in the brain. Additionally, Appendix A presents data that demonstrates Trim32 also 
localizes with Kv1.2 in hippocampal neurons, and given the mutual connection of these 
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proteins with seizure, the hippocampus may also useful venue for future experimental 
investigations of Trim32 and neuronal excitability. 
GABAergic Inhibition as a Model Role for WNK1/SPAK Modulation of Kv1.2 in 
the Brain 
The preceding work in Chapter 3 identified components of the chloride-sensitive 
WNK kinase pathway associating with Kv1.2 in the brain, and proposed a model of 
WNK1 and its downstream target SPAK providing complementary modulation of the 
channel at the cell surface. WNK1’s best described role in the literature is to activate 
SPAK/OSR1 in response to alterations of intracellular chloride, although it can have 
functionality that may be independent of its kinase domain and SPAK activation. The 
following section will provide evidence for a testable model of GABAergic inhibition of 
Purkinje cells through chloride-influenced WNK/SPAK signaling and Kv1.2 trafficking. 
Chloride Inhibits WNK1 Kinase Activation of SPAK 
Chloride inhibits WNK1 kinase activity, which primarily targets downstream 
kinases SPAK/OSR1. The chloride ion stabilizes the inactive conformation of WNK1 by 
binding the kinase domain, preventing auto-phosphorylation, and thereby preventing the 
ability of SPAK to be activated by WNK1 phosphorylation. This mechanism is what 
defines WNK1 as an intracellular chloride sensor (Piala et al., 2014). However, even with 
an inactivated kinase domain, WNK1 may still have kinase-independent functionality.   
WNK1 Traffics Membrane Proteins without Kinase Activity 
WNK1 also induces clathrin-dependent endocytosis of ROMK (Zagorska et al., 
2007) which requires binding outside its kinase domain, and mutants lacking kinase 
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activity can still inhibit the channel (H. R. Wang, Liu, & Huang, 2008). Additionally, 
WNK1 activates the Serum and Glucocorticoid-induced Kinase (SGK) 1 (SGK1) to 
impact the membrane expression of epithelial sodium channel (ENaC) by requiring only 
the N-terminal residues and not the kinase domain (B. E. Xu, Stippec, Lazrak, et al., 
2005). Given the kinase independence, these functionalities of WNK1 are also likely 
independent of chloride. 
Chloride May Determine the Route WNK1/SPAK Influence Surface Kv1.2 
As chloride inactivates WNK1 kinase activity, reduced intracellular chloride 
activates WNK kinases (Piala et al., 2014). Particularly, reduced intracellular chloride has 
been shown to activate SPAK/OSR1 and eventual major downstream targets of the 
chloride-response pathway such as NKCC1 in secreting epithelia (Lytle & Forbush, 
1996). In the case of NKCC2, the main transporter that extrudes chloride through this 
pathway in the brain (de Los Heros et al., 2014), the transporter activation by reduced 
intracellular chloride is blocked by WNK mutants that affect the WNK-SPAK docking 
interaction (Ponce-Coria et al., 2008).  
In relation to the topics of this thesis, decreased extracellular chloride reduces the 
current of Kv1.5 and Kv2.1, providing the first evidence for Cl- induced modulation of 
Kv channels. (X. Li, Surguchev, Bian, Navaratnam, & Santos-Sacchi, 2012). Hypotonic 
low-chloride conditions rapidly activate WNK kinase isoforms, including 
SPAK/OSR1(Lenertz et al., 2005). Thus, in conditions where WNK1 kinase activity is 
expected to be increased, at least some Kv channel currents are also suppressed. This is in 
line with our conclusions from Chapter 3, where SPAK or WNK1 activated SPAK 
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activity decreases Kv1.2 at the plasma membrane. If increasing chloride inside the cell 
increases Kv channel current, and if chloride inactivates WNK1 activation of SPAK, 
perhaps increased intracellular chloride triggers WNK1 to favor its SPAK-independent 
increase of Kv1.2 at the membrane surface. Along these lines, decreased intracellular 
chloride would then activate WNK1 kinase activity and, through SPAK, decrease Kv1.2 
from the surface. Experiments that directly manipulate intracellular chloride need to be 
performed to validate this model, but it seems at least possible that chloride may be the 
factor with which dictates how this signaling pathway influences Kv1.2. In the brain, 
fluctuations of intracellular chloride occur often from the neurotransmitter GABA. 
WNK1 has been hypothesized to be involved with GABAergic inhibition in the brain, but 
this concept is for the most part speculative (Alessi et al., 2014). 
Proposed Model of GABAergic Inhibition of Kv1.2 by WNK/SPAK Signaling 
GABAA receptors (GABAAR) comprise the main inhibitory neurotransmission 
system in the brain, eliciting hyperpolarization through chloride ion influx. In a previous 
publication, treatment of live cerebellar slices with gabazine, a drug that blocks GABAA 
receptors, resulted in a reduction of Kv1.2 measured at the cellular surface (Williams et 
al., 2012). In Chapter 3 and Appendix B, immunofluorescence demonstrated WNK1 and 
likely also SPAK are expressed in the GABAergic Purkinje cells of the cerebellar cortex 
which receive GABAA inhibition from interneurons such as basket cells. Binding of 
GABA to GABAA receptors promotes the passage of chloride through the channel and 
into the cell, and therefore blockade of GABAA receptors with the drug gabazine is 
hypothesized to decrease intracellular chloride and therefore increase WNK1 kinase 
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activity and thus WNK1-activation of SPAK. This suggests the following model 
illustrated in Figure 1: GABA release by cerebellar inhibitory interneurons bind PC 
GABAARs and cause an increase of [(Cl-)i]. The elevation of [(Cl-)i] decreases WNK1 
kinase activity which in turn results in increases of Kv1.2 expression at the neuronal 
plasma membrane. Kv1.2 maintained at the surface provides hyperpolarization and thus 
extends the overall GABAergic inhibition of the PC.  Conversely, under conditions where 
inhibitory neurons release less GABA, less chloride passes into the PC and the decrease 
of [(Cl-)i] allows increased activation of WNK1 kinase activity and thus favors WNK1 to 
activate SPAK and internalize Kv1.2 from the neuronal membrane.  Decreased surface 
Kv1.2 depolarizes the PC leading to enhanced excitability. Although speculative, this 
hypothesis suggests a novel and currently unexplored voltage-independent link between 




Figure 4:1 Proposed model of Kv1.2 modulation by GABA induced WNK1/SPAK 
signaling.  GABA release by cerebellar inhibitory interneurons bind PC GABAARs and 
cause an increase of [(Cl-)i]. The elevation of [(Cl-)i] decreases WNK1 kinase which in 
turn results in increases of Kv1.2 expression at the neuronal plasma membrane.  Kv1.2 
maintained at the surface provides hyperpolarization and thus extends the overall 
GABAergic inhibition of the PC.  Conversely, under conditions where inhibitory neurons 
release less GABA, less chloride passes into the PC and the decrease of [(Cl-)i] allows 
increased activation of WNK1 kinase activity and thus favors WNK1 to activate SPAK 
and internalize Kv1.2 from the neuronal membrane.  Decreased surface Kv1.2 




Are Trim32 and WNK1 Pathways Linked? 
 Determining whether Trim32 and WNK signaling modulate Kv1.2 through 
separate or linked pathways is not straightforward. The preceding work demonstrated 
complex, duel mechanisms for modulating Kv1.2 by both routes. Cellular growth 
conditions and potential patterns of post-translational modification can sway Trim32’s 
route, while endogenous WNK1 can influence whether WNK1 activates SPAK and alters 
it’s route of modulation. Additionally, compensatory effects from other WNK kinases 
and ubiquitin ligases must be accounted for. It is especially interesting to speculate that 
WNK1 or SPAK affect phosphorylation proximal to Trim32 ubiquitylation sites, since, as 
described in Chapter 2, phosphorylation at these sites influence the effect of Trim32 on 
Kv1.2 trafficking. Figure 2 demonstrates a replicate series of experiments where co-
expression of Trim32 and WNK1 together abolished the effects of either enzyme co-
expressed individually. Although tempting to infer a connection, the complex 
mechanisms by which either enzyme modulates the channel makes this result speculative 
at best.  Future experiments are needed to further examine whether Trim32 and WNK1 




Figure 4:2 Co-expression of both Trim32 and WNK1 abolishes individual effects on 
surface Kv1.2 by each enzyme.   As demonstrated in Chapters 2 and 3, co-expression of 
Trim32 (wild-type) causes Kv1.2 to significantly increase in surface expression (Chapter 
2), while, conversely, co-expression of WNK1 causes Kv1.2 to significantly decrease in 
surface expression (Chapter 3). When equal amounts of Trim32 and WNK1 were both 
co-expressed in the same cells with Kv1.2 (total amount of each was equal to the 
individual co-expressions), no significant change was observed to Kv1.2 surface 
expression. **** indicates p < 0.0001. Note: data presented in this graph was also 
separately presented in graphs of Chapters 2 and 3. 
 
Conclusions 
Altogether, this work provides novel mechanisms by which voltage-gated 
potassium channels may be regulated in the brain. Regulation of Kv1.2, the channel 
focused on in this work, can influencing neuronal excitability and ultimately behavior in 
the brain (Williams et al., 2012), and therefore this work provides framework for future 
studies investigating excitability in regard to brain function of both the normal and 
disease state. Regulation of Kv1.2 by the WNK/SPAK signaling pathway may provide 
further understanding of GABAergic inhibition in cerebellar neurons that underlie 
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numerous neuronal functionalities. Regulation of Kv1.2 by Trim32 may provide a link 
for Trim32 and neuronal excitability that could translate into a model addressing the 





APPENDIX A: DATA RELATING TO CHAPTER 2 
 
Background 
The following data presented was collected during the development of Chapter 2 
but was not incorporated into the final seven figures of the publication in preparation. 
These findings may provide further clarity and breadth to the concepts present in Chapter 
2. 
Results and Discussion 
Mutation of Either C or N Terminal Kv1.2 Lysines Cripple Trim32-induced Increase of 
Surface Channel 
HEK293 cells co-expressing Kv1.2 and Trim32WT plated to low confluence 
display increased surface Kv1.2 detection by flow cytometry compared to Kv1.2 transient 
transfection alone (+ empty vector). In Chapter 2, it was demonstrated that mutation of all 
C and N terminal lysine of Kv1.2 to arginine diminish this effect, and evidence was 
provided to demonstrate that Trim32 is able to ubiquitylate Kv1.2 in vitro at both N and 
C termini. To determine if the Trim32 induced increase of surface Kv1.2 is dependent 
solely on either channel termini, we repeated the co-expression experiments of Chapter 2 
at low confluence with Kv1.2WT, Kv1.2KR, and added Kv1.2CKR and Kv1.2NKR 
(Figure A:1A) and determined that neither mutant appeared to completely eliminate the 
effect, however the overexpression of Trim32 with Kv1.2CKR was not statistically 
significant. This suggests both termini of Kv1.2 may be impacted by Trim32 co-
expression to produce the final results observed in Chapter 5. Given the sample size (n = 
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6 each), greater power and repeat experiments are needed to conclude the degree of 
influence Trim32 has either mutant channel. 
Kvβ2 is Not Necessary for Trim32-induced Increase of Surface Kv1.2 
Kv1.2 and other Kv1 alpha subunit channels can associate with cytoplasmic 
accessory proteins called Kvβ subunits typically in a 1:1 stoichiometry. In the cerebellar 
tissue homogenates of Chapter 2, ~ half as many Kvβ subunits peptides were detected as 
were alpha subunits. Kvβ subunits, particularly Kvβ2, can impact modulation of gating, 
stability, and trafficking of the channels. Co-expression of all Kvβ subunits (1-3) with 
Kv1.2 alpha subunit promotes surface expression of Kv1.2 (Campomanes et al., 2002). 
To minimize complexity, overexpression experiments reported in Chapter 2 were 
performed in HEK cells stably expressing Kvβ2. To investigate whether Kvβ2 influences 
Trim32 modulation of surface Kv1.2, we repeated the co-expression of Kv1.2 and 
Trim32 in HEK293-ATTC cells lacking Kvβ2 (Figure A:1B). Kvβ2 was co-expressed 
into replicate experiments as a control. Empty vector was also co-expressed in cells not 
transfected with Kvβ2. No significant difference was found between the two cell lines 
under identical conditions, suggesting that Kvβ2 is not significant contributing to the 
Trim32-induced increase of surface Kv1.2. 
C24A Mutation of Trim32 Does Not Alter Trim32 Trafficking of Kv1.2 
 Mutation of cysteine 24 to alanine within Trim32’s RING domain has been 
previously reported to cause crippling of Trim32 ubiquitin ligase activity. Within the 
experiments used to determine Trim32∆RING’s effect on Kv1.2 surface expression in 
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Chapter 2, Trim32C42A was also co-expressed with Kv1.2 and determined to have no 
significant change to Trim32 induced modulation of surface Kv1.2 Figure A:1C). 
Inhibition of Clathrin-dependent Endocytosis Enhances Trim32-induced Increase of 
Surface Kv1.2 
Chapter 2 did not explicitly investigate whether the effect of Trim32 on surface 
Kv1.2 influences trafficking of the channel. Clathrin-dependent endocytosis is a major 
internalization mechanism for decreasing Kv1.2 from the PM in HEK cells (Nesti et al., 
2004; Stirling et al., 2009). Given the results of Chapter 2, where Trim32 promoted 
Kv1.2 at the cellular membrane at lower confluence conditions, we wondered if 
inhibiting clathrin-dependent endocytosis would enhance the Trim32-induced increase of 
Kv1.2. To test this, a cell-permeable inhibitor of dynamin, an essential component for 
clathrin-dependent coated vesicle formation (Macia et al., 2006), was applied to plated 
cells co-expressing Kv1.2 and either Trim32WT, Trim32∆RING, Trim32C24A, or mUb 
and the surface expression of Kv1.2 was observed. As with previous experiments, co-
expression of Trim32WT, Trim32C24A, or mUb all significantly increased surface 
Kv1.2 while Trim32∆RING did not in vehicle treated cells. In cells treated with the 
dynamin inhibitor (Dynasore), with the exception of mUb, all of these increases were 
significantly enhanced after the treatment of Dynasore (Trim32WT **, Trim32∆RING 
***, Trim32C24A***) by two-way ANOVA test. This enhancement may be a result of 
blocking endogenous trafficking mechanisms in HEK cells, possibly also incorporating 
Trim32’s mechanism to decrease surface Kv1.2 observed in highly confluent cells, 
however these details were not investigated and require further experiments.  
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Co-immunoprecipitate of Trim32 with Kv1.2 was not observed by Immunoblot from 
Tissue Lysed in Buffer Lacking DUB, Proteasome, and Phosphatase Inhibitors 
Chapter 2 detected only three peptides of Trim32 by mass spectrometry following 
IP of Kv1.2 from tissue lysed in a limited buffer (MS trail 1). To test whether this was a 
limitation of experimental detection by mass spectrometry, we immunoprecipitated either 
Kv1.2 or Trim32 from tissue lysed in the same buffer containing protease inhibitors 
(HALT cocktail of 100mM AEBSF*HCl, 80µM Aprotinin, 5mM Bestatin, E-64, 1.5mM 
EDTA, 2mM Leupeptin, and 1mM Pepstatin A) but lacking DUB, proteasome, and 
phosphatase inhibitors and used Immunoblotting to detect a potential co-IP (Figure A:2). 
Unlike the IB analysis of Chapter 2, which performed the same IPs from tissue lysed also 
in 1mM NaF, 1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132, co-
IP of either protein under these conditions was not detected. This data suggests that the 
preservation of the Kv1.2 and Trim32 association is sensitive to removal of post-
translational modifications. These inhibitors are not specific to Kv1.2 or Trim32 and 
further experiments are needed to elaborate the conclusions. 
Trim32 Co-expression Promotes High Molecular Weight Bandshifts of Kv1.2 Detected by 
Immunoblot. 
Chapter 2 highlighted the ~8.5kDa bandshift increases of Kv1.2 following co-
expression of Trim32 (or mUb). At the top portion of the gel (< 300kDa), faint, high-
molecular weight bandshifts of Kv1.2 can also be detected following Trim32 co-
expression. These bandshifts were seen in replicate experiments (Figure A:3A left and 
right) and not seen with co-expression of empty vector.  
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The RING Domain of Trim32 is not Required for the Trim32 association with Kv1.2 
To determine if Trim32s catalytic RING domain is essential for its association 
with Kv1.2, Kv1.2 was overexpressed alone, with wild-type Trim32, or with Trim32 
lacking the RING domain (Figure A:3B). Cells were lysed and prepared for Kv1.2 IP 
and immunoblot as described in Chapter 2 for tissue IB. Regardless of the RING domain, 
Trim32 was still detected to co-IP with Kv1.2, suggesting that the catalytic RING domain 
is not essential for associating with Kv1.2. Red arrows in the Trim32 co-IP channel 
indicate Trim32 and the decreased MW as a result of the deleted RING domain. 
AC Activation by Forskolin Alters the Influence of Trim32 on C-terminal 
Phosphorylation Sites of Kv1.2 
 
Under identical conditions to those described in Chapter 2, a parallel SILAC 
experiment was performed to determine the effect of Trim32 and Forskolin treatment, as 
the AC/PKA activator Forskolin has shown previously shown to influence activity of 
both Kv1.2 and Trim32 (Connors et al., 2008; Ichimura et al., 2013). The SILAC results 
of Chapter 2 are also listed as the vehicle treatment (Table A:1). As reported in Chapter 
2, co-expression of Trim32 caused no change in S440 phosphorylation but significantly 
decreased S434 phosphorylation. In cells treated with Forskolin, however, Trim32 now 
significantly decreased S440 phosphorylation and did not alter S434. These results 
suggest that AC activation by Forskolin treatment is able to manipulate the influence of 
Trim32 on Kv1.2 phosphorylation. L = Light amino acid (K/R 12C & 14N) containing 
culture media and H = Heavy amino acid (K/R 13C & 15N) containing culture media. 
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Trim32 is Present Throughout the Mammalian Brain 
In addition to isolated cerebellar slices of Chapter 2, a whole brain 
immunofluorsecent survey of Trim32 was performed by multiphoton imaging on whole 
brain, sagittal slices (Figure A:4, top left shows a cropped picture from a whole, sagittal 
image). Trim32 was found to be highly prevalent in the hippocampus particularly 
(Figure A:4, top right), where triple staining with Kv1.2 and DAPI showed that Trim32 
can also be found within the nuclei of hippocampal cells containing Kv1.2 (Figure A:4, 
bottom images). Both the cerebellar finding of Chapter 2 and hippocampal findings here 
are in agreement with recent IHC reports of human (both male and female) tissue 
provided by proteinatlas.org. Sagittal slices were cut between 10-50 µM thick, 
permeabilized in 0.3% Triton X. Slices were prepared for immunofluorescence and 
analyzed by microscopy through methods described in Chapters 2 and 3. 
Additional Mass Spectrometry Detection of Trim32 
A modified table of detection of Trim32 by LC-MS/MS which includes the 
addition of the 4 cerebellum homogenate detected by an Orbitrap mass spectrometer 
listed in Chapter 3 (Table A:2). 
Figure Legends 
Figure A:1. Additional flow cytometry data pertaining to Trim32 and ubiquitylation 
surface regulation of Kv1.2. (A) Trim32s influence on Kv1.2 is altered by C or N 
terminal lysine mutations. Figures 5 and 6 demonstrated that Trim32 modulates surface 
Kv1.2 differently dependent on cellular conditions.  Here, we tested Trim32 
overexpression on N and C terminal KR mutants and compared the results to both 
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Kv1.2WT and KV1.2KR. In this experiment, Trim32 caused a typical significant increase 
in surface Kv1.2WT also causing a significant decrease in surface Kv1.2KR. 
Overexpressing Trim32 with either Kv1.2-CKR or Kv1.2-NKR caused a modest increase 
in surface channel, with NKR but not CKR being significantly different from Kv1.2WT. 
N = 6 for each condition. * denotes significance of p < 0.05 by students t-test.  
(B) Trim32 does not require Kvβ2 to increase surface Kv1.2. Chapter 2 focused solely on 
Trim32 influence toward Kv1.2 alpha subunit. Using HEK293-ATTC cells, we found 
that removing Kvβ2 decreased baseline surface Kv1.2 but had no significant effect on 
Trim32 increasing Kv1.2 at the membrane surface. N = 6 for each Kv1.2 + vector 
condition and n = 12 for Kv1.2 + Trim32 conditions.  
(C)  GFP-Trim32C24A traffics Kv1.2 similarly to GFP-Trim32WT.  It has been 
suggested that the cysteine within Trim32’s RING domain is responsible for much of its 
ligase activity, and in some assays, replacement with an alanine can partially or 
completely cripple ligase activity. Alongside the same experiments run in Figures 5 and 
6, we observed that GFP-Trim32C24A altered surface Kv1.2 similarly and not 
significantly different to GFP-Trim32WT. 
(D) Dynamin inhibition enhances Trim32 increase of surface K1.2. To investigate the 
effect of inhibiting clathrin-dependent endocytosis to plated cells co-expressing Kv1.2 
and Trim32WT, Trim32∆RING, Trim32C24A and mUb, cells were treated the dynamin 
inhibitor Dynasore and compared to DMSO vehicle controls. Dynasore significantly 
enhanced the increase of surface Kv1.2 by all Trim32 constructs, but not mUb. N = 6 for 
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each condition. Data analyzed by 2way analysis of variance. * = p <0.05 ** = p <0.01*** 
= p <0.001 **** = p <0.0001. 
Figure A:2. Co-immunoprecipitation of Trim32 with Kv1.2 is not detected in 
cerebellar extracts without DUB, proteasome, and phosphatase inhibitors present in 
lysis buffer. 
To determine whether the low Trim32 co-IP detected by LC-MS/MS from tissue 
homogenized in lysis buffer lacking 1mM NaF, 1mM NaOrthovanadate, 20mM BAPTA, 
5mM NEM, 10 µM MG-132, the experiment was repeated and subject to WB analysis. 
No visible co-IP from either Kv1.2 or Trim32 IP was visibly detected. 
 
Figure A:3. Kv1.2 interacts with Trim32 in the absence of its RING domain. A: Wild 
type Kv1.2 was expressed alone (+empty vector) or co-expressed with either GFP-
Trim32WT. Cells were lysed and Kv1.2 protein was detected by immunoblot. Co-
expression of Trim32 with Kv1.2 produces high molecular weight bandshifts of Kv1.2 
detected in either the cell lysates or following IP of Kv1.2.  
 B: Wild type Kv1.2 was expressed alone (+empty vector) or co-expressed with either 
GFP-Trim32WT or GFP-Trim32∆RING in HEK293β2cells. Cells were lysed in the 
presence of MS Trial 3 in Chapter 2, and lysates were IP’d for Kv1.2. Proteins were 
separated by SDS-PAGE electrophoresis and analyzed by immunoblot. Probing for 
Trim32, a band of Trim32 (~100kDa) was detected from Kv1.2 + GFP-Trim32WT 
(Middle lane). A band of Trim32 was still detected from cells co-expressing Kv1.2 + 
GFP-Trim32∆RING (Right lane) with an appropriate decrease of molecular weight 
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corresponding to the deleted RING domain. Lysates show total Kv1.2 and Trim32 
proteins in both conditions, and molecular weight for Trim32 was similarly decreased 
form cultures expressing the RING mutation. 
Figure A:4. Trim32 is present throughout the rat brain. Beside the cerebellum, Kv1.2 
is endogenously expressed in other cortical regions of the brain such as the hippocampus.  
Top panel- multiphoton analysis of fixed cerebellar slices demonstrated that Trim32 is 
diffuse throughout the brain (left), particularly in the hippocampus where Kv1.2 is highly 
expressed (right). Full brain sagittal images: Adult rat cerebellar slices (400 µM) were 
fixed (2% formaldehyde cardiac perfusion), permeabilized (10% acetone), blocked, and 
stained for Kv1.2 (1:200) and Trim32 (1:100), and imaged using a Zeiss LSM 7 
multiphoton microscope and a 20X water lens. Images were analyzed in Zen 2011 
Software. Bottom panel- Widefield/deconvolution (Deltavision) images demonstrated 
Trim32 localizes to the nucleus of neurons expressing Kv1.2 within the hippocampus.  
Images obtained at 60X magnification with the same method and parameters listed in 
Chapter 2. 
 
Table A:1. Table of SILAC quantification that includes the result of Chapter 2 and 
a parallel experiment with Forskolin treatment. The SILAC results of Chapter 2 are 
listed as the vehicle treatment and compared to a parallel experiment with both Light and 
Heavy populations treated with Forskolin. Rather than decreasing S434 phosphorylation, 
Trim32 co-expressed cells treated with Forskolin now significantly decreased S440 
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phosphorylation and did not alter S434. Culture media in the Light population contained 
lysine and arginine amino acids with K = 12C6 & 14N2 and R = 12C6 & 14N4) while Heavy 
populations contained them with K = 13C6 & 15N2 and R 13C6 & 15N4.  
Table A:2. Additional detection of Trim32 by LC-MS/MS. A modified table of 
detection of Trim32 by LC-MS/MS which includes the addition of the 4 cerebellum 






Figure A:1 Additional flow cytometry data pertaining to Trim32 and ubiquitylation 




Figure A:2 Co-immunoprecipitation of Trim32 with Kv1.2 is not detected in 


















Table A:1 Table of SILAC quantification that includes the result of Chapter 2 and a 









Kv1.2 + Trim32 H/L = 1.25 H/L =1.18 H/L =1.67 H/L =0.77 
Kv1.2 + Trim32  
+ Forskolin 
H/L = 0.59 H/L = 0.25 H/L = 0.63 H/L = 0.53 
 
 
Table A:2 Additional detection of Trim32 by LC-MS/MS. 
MS Trial 1 2 3 4 
Tissue 2 cerebellum 2 cerebellum 2 cerebellum 4 cerebellum 
PTM conditions* NO YES YES YES 
Protein XCorr 3.25 3.57 3.13 3.33 
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The data presented here were collected during the experiments presented in 
Chapter 3 but were not included in the final six figures. Similarly to Appendix A for 
Chapter 2, this data is intended to expand the clarity and depth of Chapter 3.  
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Results and Discussion 
Hypertonic Stress Alters WNK1-Induced Modulation of Surface Kv1.2 in WNK1KO 293T 
but not Control 293T Cells. 
Since co-expression of WNK1 alters surface Kv1.2 in HEK293 cells, and WNK1 
is an intrinsic sensor of cell volume, we wondered if altering extracellular tonicity would 
impact the influence WNK1 has on Kv1.2 surface expression. High extracellular NaCl 
produces a hypertonic extracellular environment which has previously been shown to 
stimulate autophosphorylation and activation of endogenous WNK1 in HEK cells (B. Xu 
et al., 2000). Hyperosmotic stress also induces a rapid localization of WNK1 to clathrin-
coated vesicles (Zagorska et al., 2007). Just as Chapter 3, experiments were performed in 
both HEK293T-cells and WNK1KO cells co-expressing Kv1.2 and WNK1 (or empty 
vector). Surface Kv1.2 in cells treated with high NaCl (0.4M, 20 minutes) was compared 
to isotonic controls treated with vehicle (PBS) (Figure B:1). High extracellular NaCl 
alone had no effect on Kv1.2 surface expression (+3%, t(df) = 0.44(16), p = 0.6629, n = 
12 (isotonic), 6 (hypertonic), and co-transfection of WNK1 caused a significant decrease 
of surface Kv1.2 similar to isotonic conditions (-12%, t(df) =  2.96(10), p < 0.05, n = 12 
(isotonic), 6 (hypertonic).  As observed in Chapter 3, switching from HEK293T-cells to 
WNK1KO cells significantly decreased baseline Kv1.2 (-9%, t(df) =  2.28(10), p < 0.05, 
n = 12 (isotonic), 6 (hypertonic). However, unlike isotonic conditions, co-transfection of 
WNK1 in WNK1KO cells caused a significant decrease of surface Kv1.2 (-15%,  t(df) =  
2.34(10), p <0.05, 12 (isotonic), 6 (hypertonic) after NaCl exposure, suggesting that the 
mechanism driving increased surface Kv1.2 does not occur during hypertonic stress. In 
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addition to activation of WNK kinases, hypertonic stress promotes both the binding and 
activation of downstream SPAK/OSR1 kinases by WNK kinases (Zagorska et al., 2007), 
supporting the idea that the decrease of surface Kv1.2 by Trim32 over-expression is 
through SPAK activation. 
WNK1 Localizes to Ring-like Structures in PC Soma 
In a repeat IF experiment for Chapter 3, again, WNK1 is strongly localized in the 
molecular layer with Kv1.2, however WNK1 also displays a unique, ring-like structures 
within the PC bodies (Figure A:2A Top panel). Additionally, WNK1 also is found with 
punctate structures that surround the cell body of the PC which overlap with Kv1.2. A 
magnification of a PC soma with a surrounding Pinceau is provided for further clarity 
(Figure A:2A, insert). Further experiments are needed to determine whether the ring-like 
structure is in fact nuclear or peri-nuclear in localization as well as to determine the true 
function of the puncta. 
SPAK May also Localize to Purkinje Cells 
Given the localization of WNK1 determined in Chapter 3, and the fact that 
WNK1 and SPAK share a similar signaling pathway, SPAK is likely also localized to 
PCs and molecular layer neurons.  Using multiphoton imaging similar to Chapter 3, 
SPAK was also detected, although at weaker resolution, within all cerebellar locations, 
most particularly in PCs and within the molecular layer by multiphoton microscopy 
(Figure B:2B, Middle panel).  Additional imaging with high magnification (100X) 
widefield microscopy with DeltaVision restoration demonstrated SPAK diffuse within 
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the molecular layer and PCs (Figure B:2B, Bottom panel).  Perinuclear ring-like 
structure similar to that seen with WNK1 by multiphoton (Figure B:2B, Insert).     
SPAK Peptide Fragmentation Spectra with Phosphorylation at Threonine T240 
SPAK is phosphorylated and subsequently activated by WNK1 at an equivalent 
threonine found across mammals: T233 in human, T243 in mice, and here T240 in rat.  
Chapter 3 presented several peptides of SPAK T240 that were found phosphorylated in 
cerebellar tissue enriched for Kv1.2, however the spectra were not shown.  Figure 3 
provides a representative spectra detected from Chapter 3 experiments. Peptide charge = 
+3, Xcorr = 2.57, localization determined by manual inspection. 
Figure Legends 
 
Figure 1. Extracellular hypertonic treatment of HEK293 cells and response of Kv1.2 
surface expression. HEK293T control or WNK1KO cells co-transfected with Kv1.2 and 
WNK1 or empty vector were treated with either isotonic or hypertonic (0.4M, NaCl) 
media for 20 minutes prior to surface expression measure by flow cytometry. Control 
293T cells caused a significant decrease of surface Kv1.2 in both conditions, and 
hypertonic media alone did not alter baseline expression of Kv1.2. Switching from T 
cells to WNK1KO cells, as before, decreased baseline surface Kv1.2 in both conditions, 
however co-expression of WNK1 caused a significant decrease of surface channel 
equivalent to that of the T cells, rather than the significant increase demonstrated under 
prior experiments and isotonic conditions here. 
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Figure 2. SPAK localization in the cerebellum and Possible WNK1 trans-golgi and 
vesicular localization in cerebellar Purkinje cells. A: Multiphoton imaging 
highlighting the ring-like structure that WNK1 (pseudo colored green) often demonstrates 
in PC cell bodies. Other cerebellar interneurons (BC, stellate) can be seen as well as what 
may be Burgmann Glia between (large, green structures between PCs). Note: colors are 
reversed to those of Chapter 3 imaging. B: Imaging of SPAK by both Multiphoton (top) 
and Widefield/deconvolution (bottom) Microscopy collectively display what appears as 
localization to both PCs and the molecular layer, however repeat experiment with 
improved detection are needed.  
 
Figure 3. SPAK T240 phosphorylation spectra in the cerebellum.  SPAK is 
phosphorylated and subsequently activated by WNK1 at an equivalent threonine found 
across mammals: T233 in human, T243 in mice, and here T240 in rat.  Chapter 3 
presented several peptides of SPAK T240 and a representative peptide spectra is shown 
(Peptide charge = +3, Xcorr = 2.57).  All LC-MS/MS preparation and analysis were 




Figure B:1 Extracellular hypertonic treatment of HEK293 cells and response of 




Figure B:2 SPAK localization in the cerebellum and Possible WNK1 trans-golgi and 




Figure B:3 SPAK T240 phosphorylation spectra detected in cerebellar tissue 







Table B:1 MS detection of SPAK. 
MS Trial 1 2 3 4 5 
Tissue 2 cerebellum 2 cerebellum 2 cerebellum 2 cerebellum 4 cerebellum 
PTM conditions* NO YES YES YES YES 
Protein XCorr 3.29 3.94 3.81 3.65 3.71 
Total Peptides 21 9 9 14 13 
 
Table B:2 MS detection of WNK1. 
MS Trial 1 2 3** 
Tissue 2 cerebellum 6 cerebellum 2 cerebellum 
PTM conditions* YES YES YES 
Protein XCorr 2.87 2.81 2.87 





APPENDIX C: ADDITIONAL MASS SPECTROMETRY DATA 
 
Background 
This section provides supplementary mass spectrometry data which was obtained 
throughout the generation of Chapters 2 and 3. 
Results and Discussion 
 
Forskolin Alters S440 Phosphorylation of Kv1.2 in Cerebellar Slices 
 
Recently, application of the neuropeptide secretin to live cerebellar slices was 
shown to result in altered trafficking of Kv1.2 through AC/PKA activation (Williams et 
al., 2012). As mentioned in previous chapters, AC stimulation by Forskolin treatment has 
also been shown to alter S440 phosphorylation in HEK293 cells (Connors et al., 2008).  
To test whether stimulation of AC/PKA to cerebellar slices leads to altered 
phosphorylation at S440, we stimulated live slices with Forskolin and used Absolute 
Quantification of Peptides (AQUA) quantitative MS analysis. The AQUA peptide was 
identical to the commonly detected doubly charged, singly phosphorylated peptide 
IPSpSPDLKK with the addition of 13C6 to the leucine (L444) and was detected prior to 
experimentation at 526.38 m/z. AQUA analysis showed that Forskolin treated slices 
resulted in ~50% increased S440 phosphorylation compared to DMSO vehicle treated 
slices (Figure C:1). Because of overall weak detection of Kv1.2 in the samples, MS2 
fragmentation spectra was not obtained for all +2 peptides quantified and therefore S441 
phosphorylation cannot be ruled out and interpretation may therefore be limited to 
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combined S440 and S441 phosphorylation. Regardless, AC/PKA activation by Forskolin 
treatment appears to impact both surface expression (Williams et al., 2012) and 
phosphoryalation of Kv1.2 in cerebellar slices. 
Kv1.2 Post-translational Modifications Detected by LC-MS/MS with Unknown 
Functionality  
A recent, large-scale proteomic study reported a peptide of Kv1.2 ubiquitylated at 
K45 and K63 isolated from mouse tissue (Wagner et al., 2012). In Chapter 2, we reported 
identification of these two sites on a single peptide detected in MS Trial 2. The spectra is 
presented here in Figure C:2. Mass addition of lysine 45 was well localized (b5, b6 and 
y16 ions detected), however, mass addition by di-GG of adjacent K63 and K64 was 
difficult to localize (although y2, y3, and b19 were suggestive of K63). The peptide 
charge was +3 with a Sequest Xcorr value of 2.2. Sample preparation and analysis by 
LC-MS/MS was identical to Chapter 2. Functional roles for these sites remained to be 
elucidated. 
Another site of Kv1.2 modulation detected in mouse tissue by Wagner et. al. was 
serine 468 phosphorylation. This site has not been reported in rat tissue or localized to the 
cerebellum, nor does a functional role for this PTM exist. We detected this site 
abundantly phosphorylated in cerebellar tissue (Xcorr values as high as 5.0). An example 
spectra is shown in Figure C:3 (Charge = +3, Xcorr = 5.4, A score = 119). Additionally, 
detection of phosphosites of this peptide by LC-MS/MS analysis following cerebellum-
dependent learning in Chapter 3 was noted, however a functional link was not determined 
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nor were the results truly quantitative. Further validation is needed to determine whether 
phosphorylation of S468 is truly related to cerebellum-dependent learning.   
Comparison of Kv1.1 S439 and Kv1.2 Modified Peptides 
 Sequence alignment of Kv1.2 with that of Kv1.1 shows that Kv1.1 does not have 
a homologous lysine or arginine in this region of its C-terminus (Figure 5). The resultant 
tryptic peptide is of similar length to the peptide of Kv1.2 with K437 ubiquitylation. 
Serine 439, homologous to S440 of Kv1.2, was often detected phosphorylated and 
produced a tryptic peptide with similar length and general fragmentation pattern for 
comparison of Kv1.2 K437 ubiquitylation. 
Figure Legends 
 
Figure C:1. Forskolin alters S440 phosphorylation of Kv1.2 in vivo.  Treatment of 
Forskolin (100µM, 15min) to cerebellar slices resulted in approximately twice as many 
Kv1.2 S440 phosphopeptides compared to DMSO vehicle treated slices as detected by 
Absolute Quantification LC-MS/MS (run on an LTQ Orbitrap Discovery mass 
spectrometer with mass accuracy ~0.05Da).  Figure shows MS1 spectra and LC elution 
insert from DMOS condition only. Spectra demonstrates successful detection of both 
light (endogenous) and heavy (synthetic) peptides, while quantitative ratios of light/heavy 





Figure C:2. N-terminal Kv1.2 ubiquitylated peptide detected by MS. Ubiquitylation 
at K45 and K63 was detected on a single peptide from MS trail 2. Within the peptide, the 
first –GG motif was well localized to K45 while other was likely at K63 upon manual 
inspection of fragmentation, although K64 was not able to be ruled out (Peptide charge 
+3, Xcorr = 2.2). Preparation of sample and analysis of LC-MS/MS was described in 
Chapter 2 (Also pertains to Figure C:3 and Figure C:4 below). 
 
Figure C:3. Peptide fragmentation spectra of Kv1.2 phosphorylation at S468. 
Phosphopeptides containing serine 468 phosphorylation were detected in all tissue 
experiments and mentioned in the behavioral experiment of Chapter 3. A representative 
fragmentation spectra of this phosphopeptide is shown (Charge = +3, Xcorr = 5.44, A 
score = 119).  
 
Figure C:4. Kv1.1 Sequence and fragmentation spectra comparison of Kv1.2 437 
ubiquitylation and Kv1.1 S439 phosphorylation. Kv1.1 does not possess a lysine or 
arginine equivalent to the region of Kv1.2 K437, and tryptic peptides are cut in similar 
length to the commonly detected +3 K437 ubiquitylated peptide of Kv1.2.  This peptide 
was often detected phosphorylated at a S439, homologous to S440 of Kv1.2.  The two 




Table 1. Total PTMs detected by LC-MS/MS for Kv1.2. A comprehensive list of all 
PTMs identified in cerebellar tissue by mass spectrometry. All sites were identified by 
matching LC-M/MS fragmentation spectra to Sequest database spectra  with mass 
tolerance of +/- 1 Da.  Localization of all PTMs were confirmed by manual inspection. 
Table 2. Total PTMs detected by LC-MS/MS for Kv1.1. A comprehensive list of all 
PTMs identified in cerebellar tissue by mass spectrometry similarly to Table 1 for Kv1.2. 
 
Table 3. Complete Linear Quadrapole LC-MS/MS interactome of Kv1.2 from 
Chapter 2 MS trail 1. All proteins identified contained at least 3 unique peptides 
detected in the experimental and none detected in the equivalent controls. 
 
Table 4. Complete Liner Quadrapole LC-MS/MS interactome of Kv1.2 from 
Chapter 2 MS trails 2 and 3 combined (3 includes entire gel). As Table 2, all proteins 
identified contained at least 3 unique peptides detected in the experimental and none 


















Figure C:4 Kv1.1 Sequence and fragmentation spectra comparison of Kv1.2 437 
ubiquitylation and Kv1.1 S439 phosphorylation. 
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Table C:1 Total PTMs detected by LC-MS/MS for Kv1.2. 
Site Best Score # experiments Localization Charge Location 
S434 Xcorr = 4.3 4 A score = 143 +2/+3 C-term 
S440 Xcorr = 2.9 2 PhosphoRS = 
95.5% 
+2 C-term 
S441 Xcorr = 2.9 4 A score = 76 
pRS = 99.8% 
+2 C-term 
S440/S441 Xcorr = 2.8 3 100% +2 C-term 
S449 Xcorr = 1.7 1 Manual +2 C-term 
S468 Xcorr = 5.4 3 A score = 119 +2 C-term 
S308/S311 Xcorr = 2.3 4 A score = 37, 37 +2 S4 voltage 
sensing domain 
K437 Xcorr = 2.4 4 Manual +3 C-term 
K478 Xcorr = 1.86 2 100% +3 C term 
K45/K63 or 
K64 
Xcorr = 2.16 1 Manuel +3 N-term 
 
Table C:2 Total PTMs detected by LC-MS/MS for Kv1.1. 
Site Best Score # experiments Localization Charge Location 
S5 Mascot score 
82 
2 Manuel +3 N-term 
S23 Mascot score 
77 
2 PhosphoRS = 
83.3% 
+3 N-term 
S13 Xcorr = 2.7 1  +2 N-term 
T2/S5 Xcorr = 4.0 2 pRS 100%, 
100% 
+3 N-term 




Table C:3 Complete Interactome of Kv1.2 from Chapter 2 MS trial 1. 
Unique Total AVG Gene Symbol 
16 29 3.6772 Kcna1 
14 22 3.6861 Atp1a2 
11 16 3.6226 Atp2a2 
10 20 3.8376 Kcna2 
10 18 3.4533 Stk39 
10 12 3.3173 Nsf 
8 14 3.7763 Atp1a1 
8 9 3.4153 Atp1a3 
5 8 3.3389 Hspa2 
5 7 3.0597 Slc1a6 
4 7 4.0188 Kcna6 
4 7 3.7124 Hspa1b;Hspa1a 
4 5 2.639 Atp5b 
4 5 2.6042 Slc25a13 
4 4 2.6181 RGD1561141 
3 6 3.1888 Hspa5 
3 5 2.9615 Tubb5 
3 4 2.8513 Kcna4 
3 3 3.7825 Kcna3 
3 3 3.3863 Sv2a 
3 3 3.244 Trim32 
3 3 2.8208 Pfkm 
3 3 2.7644 Slc1a2 
 
 
Table C:4 Complete Interactome of Kv1.2 from Chapter 2 MS trials 2 and 3 . 
Unique Total Protein X Corr Gene Symbol MS trial identifed 
17 78 3.51 Kcna1 2 and 3 
17 54 3.8551 Kcna2 2 and 3 
17 78 3.51 Kcna1 2 and 3 
16 33 3.6003 Kcnab2 2 and 3 
15 25 3.4195 Pfkp 2 and 3 
14 22 3.931 Dpysl4 2 and 3 
12 16 3.5827 Kcnab1 2 and 3 
10 19 3.5618 Immt 2 and 3 
10 15 3.4622 Skiv2l2 3 
10 12 2.8711 Wnk1 3 
9 22 3.3511 Trim32 2 and 3 
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9 15 4.0641 Idh3B 3 
7 18 3.5462 Prkcg 2 and 3 
7 16 3.872 Acsbg1 2 and 3 
6 25 3.6932 Kcna3 2 and 3 
6 9 3.2571 Ap1b1 2 and 3 
6 8 3.6751 Cct6a 2 and 3 
6 8 3.5669 Ap2a1 3 
6 8 3.3293 UNCHARACTERIZED 3 
6 8 2.801 RGD1307284 3 
6 7 3.3236 Gls 2 and 3 
6 7 3.1803 Irs2 3 
6 7 3.1 Maoa 3 
5 10 3.5057 Kcna4 2 and 3 
5 9 3.3113 RGD1309586 2 and 3 
5 8 4.2538 Pfkl 2 and 3 
5 8 3.4364 Copa 2 and 3 
5 7 3.4613 Dlg2 2 and 3 
4 18 3.8773 Stk39 2 and 3 
4 7 3.6878 Idh2 3 
4 7 3.3739 Kif5c 3 
4 6 3.4102 Rars 2 and 3 
4 6 3.197 Hspa12a 2 and 3 
4 6 2.6938 Atad3a 3 
4 5 3.3018 Dmxl2 3 
4 5 3.2709 Aldh1l1 2 and 3 
4 4 3.4811 Iars2 3 
4 4 3.0065 Map1b 2 and 3 
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